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 Despite its medical importance, our understanding of the mechanisms and 
regulation of human parturition remains limited.  Births occurring before 37 weeks 
gestation are considered preterm and account for significant neonatal morbidity and 
mortality in this country (Saigal and Doyle 2008).  Gestational membranes, which 
provide a barrier between the fetus and mother, may be an important source of 
prostaglandins and inflammatory cytokines for signaling the onset of parturition in 
humans (Keelan, Blumenstein et al. 2003).  Bacterial infection is a leading cause of 
preterm birth, and along with cases of unknown etiology, is often associated with a 
generalized inflammatory response (Romero, Espinoza et al. 2007).  Because human 
gestational membranes are normally discarded following birth, they provide a unique 
opportunity to probe mechanisms of environmental modulation of term and preterm 
parturition in humans.  
Public Health Significance of Preterm Birth 
Preterm birth is a significant public health concern in the USA and worldwide.  
The incidence of preterm births, those occurring before 37 weeks gestation, has risen in 
the USA despite advances in prenatal care.  In the US in 2005, 12.79% of infants were 
born prematurely, which is an increase of more than 20% from 10.6% of all births in 
1990 (Martin, Hamilton et al. 2007).  In 2004, prematurity-related outcomes were 
responsible for 36.5% of all neonatal deaths (Mathews and MacDorman 2007).  In 
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addition, preterm delivery results in complications such as respiratory distress syndrome, 
apnea, intraventricular hemorrhage, patent ductus arteriosis, necrotizing enterocolitis, 
retinopathy, jaundice, anemia, bronchopulmonary dysplasia, and infections (Saigal and 
Doyle 2008).  Many of these disorders develop into chronic health problems such as 
blindness, deafness, cerebral palsy, lower IQ, and subnormal height.   
The majority of preterm deliveries are caused by spontaneous preterm labor 
(45%) or preterm premature rupture of the membranes (25%); together they are referred 
to as spontaneous preterm birth (Goldenberg, Culhane et al. 2008).  Maternal risk factors 
for spontaneous preterm birth include previous preterm delivery, African-American or 
Afro-Caribbean heritage, low socioeconomic and educational status, low and high 
maternal ages, stressful work conditions (long hours or hard physical labor), short 
interpregnancy interval, low body-mass index, undernutrition, multi-fetal gestation, 
periodontal disease, uterine infection, infection at remote sites from the uterus, and 
cigarette smoking (Goldenberg, Culhane et al. 2008).  For the most part, these risk factors 
do not suggest a mechanism.  However, inflammation may be an underlying factor in 
many of these circumstances (Goldenberg, Culhane et al. 2008). 
Gestational Membranes 
The gestational membranes extend from the placenta proper and surround the 
fetus during pregnancy, making a water tight barrier to enclose the fetus and amniotic 
fluid.  These membranes are comprised of three fused tissue layers that are of maternal 
and fetal origins (Fig.1.1).  The amnion is an epithelial barrier of fetal origin that faces 
the fetal compartment.  The subepithelial mesenchymal layer is comprised of a compact 
collagen layer that lends strength to the membranes.  The collagen matrix is interspersed 
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with fibroblast cells and has both amnion and chorion components.  The middle layer, 
called the chorion, is comprised primarily of trophoblast cells of fetal origin.  The 
decidua is maternal in origin and is adjacent to the uterine myometrium.  The amnion can 
separate naturally or be blunt dissected from the choriodecidua.  Hereafter, “intact” 
gestational membranes refers to membranes in which the three layers remain fused to one 
another. The close proximity of the gestational membranes to the uterine myometrium 
may allow for passage of biochemical signals between these tissues.  
Role of Prostaglandins in Parturition 
Parturition is highly regulated by a variety of interdependent mechanistic checks 
and balances.  Myometrial contractions arise from a combination of the release from 
inhibitory controls and acquisition of the ability to respond to contraction promoting 
stimuli (Gibb and Challis 2002).  Phase one of parturition involves the activation of the 
myometrium, which is driven by maturation of the fetal hypothalamic-pituitary-adrenal 
axis and mechanical stretch of the uterus (Gibb and Challis 2002).  Upon activation of the 
uterus, multiple stimulatory pathways result in myometrial contractility.  Interdependent 
effectors of myometrial contractility include prostaglandins, estrogens, oxytocin, and 
corticotrophin releasing hormone (Weiss 2000).   
The prostaglandin pathway is an important component of parturition that is 
susceptible to perturbation by the environment.  Prostaglandins are made in human 
placenta, gestational membranes and myometrium and cause uterine contraction and 
cervical ripening.  Prostaglandin E2 and PGF2α are potent stimulators of myometrial 
contractility and are elevated in women experiencing pre-term and term labor (Kinoshita, 
Satoh et al. 1984; McCoshen, Hoffman et al. 1990);(Kredentser, Embree et al. 1995).  
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The central role of prostaglandins in regulating myometrial contractility is evidenced by 
their common usage to induce labor clinically.   Although prostaglandin inhibitors could 
theoretically be utilized as tocolytics to treat preterm labor, clinical use is limited because 
of unwanted fetal side effects (Loudon, Groom et al. 2003).   
The prostaglandin synthesis and metabolic pathway is depicted in Figure 1.2.  
Prostaglandins are derived from arachidonic acid (AA), which is released from 
phospholipids in the cell membrane by phospholipases.  Arachidonic acid is converted to 
prostaglandin H (PGH) by prostaglandin endoperoxide H synthase (PGHS; also 
commonly known as cyclooxygenase or COX).  Although both PGHS-1 and PGHS-2 
contribute to PGH synthesis, PGHS-2 is the principle enzyme induced in human 
gestational tissues at the time of parturition and is responsible for the increased PGH 
formation seen then (Gibb and Challis 2002).  PGH is converted to PGE2 or PGF2α by 
PGE synthase or PGF synthase, respectively (Sales and Jabbour 2003).   PGHS is located 
throughout the membranes, but predominance of PGE synthase in the amnion and both 
PGE synthase and PGF synthase in the choriodecidua determines the isoforms released 
from either side of the membranes (Sawdy, Dennes et al. 1999).  Prostaglandin isomers 
are inactivated by 15-hydroxy-prostaglandin dehydrogenase (PGDH), which is present in 
the chorion.  It has been proposed that localization of PGDH in the chorion may prevent 
passage of prostaglandins from the gestational membranes to the underlying myometrium 
(Challis, Patel et al. 1999).   
The enzymes in the prostaglandin pathway are subject to a variety of regulatory 
mechanisms.  As depicted in Figure 1.2, hormones, inflammatory cytokines, and growth 
factors influence the activity of the phospholipases PGHS-2 and PGDH (Sales and 
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Jabbour 2003).  For instance, the inflammatory cytokine interleukin 1β (IL-1β) enhances 
PGE2 production in human amnion cells.  Cells treated with IL-1β showed an increase in 
both PLA2 and PGHS-2 mRNA and a decrease in PGDH mRNA (Sales and Jabbour 
2003).  It is thought that nuclear factor-κB (NF-κB) mediates the effects of inflammatory 
cytokines such as IL-1β on enzyme mRNA expression (Patel, Funder et al. 2003).  
Glucocorticoids increase PGE2 production in the chorion and amnion (Whittle, Patel et al. 
2001).  Biologically relevant concentrations of estradiol inhibit PGE2 production from 
perfused human term placentas in a concentration-dependent manner.  The inhibitory 
effect of estradiol is reversed with the concurrent administration of progesterone (Siler-
Khodr, Kang et al. 1996). 
Infection, Inflammation and Lipopolysaccharide 
 Gestational tissues collected from preterm births show overt signs of microbial 
infection in 25-40% of cases (Goldenberg, Culhane et al. 2008).  Microbial infection 
causes an immune response with release of inflammatory cytokines, and activation and 
mobilization of immune cells.  Most often, intrauterine microorganisms result from 
ascending infections where bacteria or yeast present in the vagina traverse the cervix and 
colonize the decidua (Pararas, Skevaki et al. 2006).  Microorganisms can cross the 
gestational membranes, in some cases resulting in intraamniotic and/or fetal infection 
(Romero, Espinoza et al. 2007).  Bacterial DNA is detected in as many as 70% of 
gestational membranes from elective term cesarean deliveries indicating that presence of 
bacteria alone is not enough to cause preterm delivery (Steel, Malatos et al. 2005).  Other 
factors that promote inflammation or inhibit the ability of the immune system to fight off 
infection must contribute to preterm births.   
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Lipopolysaccharide (LPS) is a cell membrane component from gram negative 
bacteria that elicits a strong immune response and may be an important signaling 
molecule in cases of intrauterine infection and preterm birth (Romero, Espinoza et al. 
2007).  It is commonly used as a model inflammatory agent.  In mouse models of preterm 
labor and birth, LPS injected into the cervix causes preterm expulsion of the fetuses 
(Reznikov, Fantuzzi et al. 1999).   
Lipopolysaccharide stimulates prostaglandin synthesis by inducing enzymes of 
the prostaglandin synthetic pathway, particularly PGHS-2 (Brown, Alvi et al. 1998).  LPS 
may also affect prostaglandin production indirectly by inducing production of 
inflammatory cytokines such as tumor necrosis factor-α.  This cytokine induced PGHS-2 
and decreases PGDH resulting in increased prostaglandin levels  (Sato, Keelan et al. 
2003).  Experimental usage of LPS presents an opportunity to manipulate gestational 
membranes ex vivo in order to understand signals generated by the gestational 
membranes under inflammatory conditions. 
Polychlorinated Biphenyls 
The persistent organic toxicants, polychlorinated biphenyls (PCBs), are 
ubiquitously present in the soil, groundwater and sediment, and consequently 
bioaccumulate in the food chain (Patandin, Koopman-Esseboom et al. 1998).  Body 
burdens above typical background levels are due to occupational exposures or 
consumption of specific food products such as Great Lakes sport fish (Stewart, Darvill et 
al. 1999).  In humans these toxicants have long half-lives (~10 years) because they are 
lipophilic and poorly metabolized (Jacobson, Fein et al. 1984).  
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Previous research has established that PCBs are present in the placenta and uterus 
during pregnancy.  In one study, the extracted lipids of the uterine muscle, placenta and 
amniotic fluid had relatively high levels of PCBs compared to maternal serum, with the 
highest levels being in the lipids of the amniotic fluid (Polishuk, Wassermann et al. 
1977). A more contemporary study of women exposed to background levels of 
environmental pollutants found one in three amniotic fluid samples contained detectable 
levels PCBs (Foster, Chan et al. 2000).  The immediacy of these toxicants to sites of 
uteroplacental prostaglandin synthesis, metabolism and action creates the potential for 
toxicant disruption of the concentration, distribution and activity of prostaglandins. 
Known actions of PCBs establish plausible mechanisms for disruption of 
prostaglandins during pregnancy.  2,4,5,2’,4’,5-hexachlorinated biphenyl (PCB 153) is a 
predominate coplanar congener found in the environment (Dabrowska, Fisher et al. 
2006).  A coplanar PCB mixture including PCB 153 induced expression of prostaglandin 
endoperoxide H synthase-2 (PGHS-2) mRNA and reduced expression of interleukin-1β 
(IL-1β) mRNA in rabbit pre-implantation embryos (Kietz and Fischer 2003). In human 
mast cells, PCB 153 caused induction of PGHS-2 and intrleukin-6 (IL-6) mRNA by a 
nuclear factor-κB (NF-κB) dependent mechanism (Kwon, Lee et al. 2002).  Because 
PGHS-2, IL-1β, IL-6 and NF-κB are important mediators of prostaglandin production in 
human pregnancy, their modulation by PCBs suggests a mechanism for toxicant 
disruption of parturition.   
The high incidence of parturition complications, combined with the negative 
health impacts associated with these events, point to the need to investigate the 
underlying causes.  Gestational membranes may be a key regulator of the inflammatory 
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status with in the uterus. Understanding the underlying causes of preterm birth will help 




Figure 1.1  Hematoxylin and eosin stained section of human gestational membranes 
from Cesarean section delivery.  The human gestational membranes are compromised 
of three main tissue layers.  The amnion, adjacent to the fetal compartment, has a single 
layer of epithelial cells.  The mesenchymal layer underlying the epithelium is comprised 
of a collagen matrix interspersed with fibroblast cells.  Chorion trophoblast cells stain 
blue, and decidua is adjacent to the uterine myometrium.  Amnion and chorion are of 






Figure 1.2  Prostaglandin synthesis and regulation.  Membrane phospholipids are 
cleaved by phospholipases (PLA) to release arachidonic acid.  Arachidonic acid is further 
metabolized by prostaglandin endoperoxide H synthase (PGHS) to prostaglandin H 
(PGH).  Species-specific prostaglandin synthases convert the PGH to prostaglandin E2 
(PGE2) or prostaglandin F2α (PGF2α). 15-Hydroxy prostaglandin dehydrogenase (PGDH) 
catatabolizes terminal prostaglandins into inactive metabolites.  Prostaglandins and 
pathway intermediates are shown in red, enzymes are in blue and potential modulators of 
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A Transwell system was designed to study the dynamics of uterotonic 
prostaglandin synthesis from the fetal and maternal sides of the gestational membrane 
after in vitro exposure to lipopolysaccharide or environmental toxicants.  In this system, 
intact gestational membranes comprised of amnion, chorion and decidua were mounted 
on a Transwell frame to create distinct chambers on either side of the membranes.  This 
culture system allowed for selective exogenous stimulation and sampling of either side of 
the membrane for studying stimulated release of prostaglandins from the amnion or 
choriodecidua.  Establishment of the in vitro Transwell culture of human gestational 
membranes required attainment of three goals: 1) optimization of specimen collection 
and transport to the laboratory, 2) optimization of culture and treatment conditions 
allowing discrete measurements of secreted prostaglandins and cytokines from the 
amnion and choriodecidua, and 3) determination of appropriate methods of data analysis.  
During initial work, high levels of between-subject and within-subject variability in 
response to treatment were seen.  To combat these problems, procedures for prompt 
acquisition of the tissue specimens after delivery were established.  Furthermore, 
optimization of the culture technique included culture with 1% fetal bovine serum, 
frequent media changes, and an 18-24 h equilibration period before experimental 
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conditions were started.  These approaches resulted in improved health of the tissue and 
reduced prostaglandin variability of response to treatments.  Three samples from each 
subject were exposed to each treatment in separate culture wells and prostaglandin 
concentrations from the culture medium were normalized to the weight of the sample.  
Other methods of normalization did not improve the variability or statistical power.  This 
optimized gestational membrane Transwell culture system and data analysis allowed ex 
vivo stimulation of human gestational membranes while maintaining cell-to-cell and 
tissue-to-tissue interactions important for processing of inflammatory signals and enabled 
side-specific measurement of prostaglandins. 
INTRODUCTION 
A Transwell system was designed to study the dynamics of uterotonic 
prostaglandin synthesis from the fetal and maternal sides of the gestational membranes 
after in vitro exposure to lipopolysaccharide or environmental toxicants.  Distinguishing 
which layer(s) of the gestational membranes produce prostaglandins is of fundamental 
importance for understanding the role of gestational membranes in mediating uterine 
contractions and parturition. Furthermore, this system enables the study of signal 
transduction across the membranes when only the fetal or maternal side of the 
membranes is stimulated.  
 Gestational membranes extend from the placenta proper and surround the fetus 
during pregnancy, making a water tight barrier to enclose the fetus and amniotic fluid.  
These membranes are comprised of three fused tissue layers which are of maternal and 
fetal origins.  The amnion is an epithelial barrier of fetal origin that faces the fetal 
compartment.  The middle layer, called the chorion, is comprised primarily of trophoblast 
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cells of fetal origin.  The decidua is of maternal origin and is adjacent to the uterine 
myometrium.  The amnion can separate naturally or be blunt dissected from the 
choriodecidua.  Hereafter, “intact” gestational membranes refers to membranes in which 
the three layers remained fused to one another.  
 The close proximity of the gestational membranes to the uterine myometrium 
may allow for passage of biochemical signals between these tissues. In particular, 
gestational membranes make and secrete uterotonic prostaglandins such as prostaglandin 
E2 (PGE2) and prostaglandin F2α (PGF2α).  Experiments comparing prostaglandin 
secretion from term gestational membranes collected from non-laboring Cesarean section 
deliveries and laboring vaginal deliveries show that membranes from laboring situations 
have increased prostaglandin production (Kinoshita, Satoh et al. 1984; McCoshen, 
Hoffman et al. 1990; Kredentser, Embree et al. 1995).  This may indicate that gestational 
membranes are a source of prostaglandins during labor. 
Current knowledge regarding the importance of gestational membrane 
prostaglandin signaling in myometrial contractility is limited.  A predominating theory to 
explain preterm labor is that PGE2 from the amnion prematurely crosses the chorion and 
decidua to cause uterine contractions (Challis, Patel et al. 1999).  However, this widely 
published theory does not explain how prostaglandins cross the gestational membranes 
given that they are anionic at physiological pH, which hinders passive diffusion across 
cellular membranes.  Determining the source of prostaglandins from within gestational 
membranes may shed light on this conundrum. 
The strategy I adopted made use of a Transwell device to create distinct chambers 
on the amnion or choriodecidual side of the membranes (Fig. 2.1).  In this system, intact 
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gestational membranes comprised of amnion, chorion and decidua were mounted on a 
Transwell frame to create a water-tight barrier.  The Transwell device with the gestational 
membranes attached was placed in a culture dish with medium on both sides of the 
membrane.  This culture system allowed for selective exogenous stimulation of the 
membranes and independent sampling of prostaglandins in the culture medium on the 
amnion or choriodecidual sides of the membrane.  
Previous development of gestational membrane dual chamber-type systems was 
limited.  Nakla, et al. (1986) mounted gestational membranes on a 4 cm perspex cylinder 
with a Teflon band and cultured them in a beaker.  Though their system was limited by 
the crude culture device, they were able to measure passage of radiolabeled 
prostaglandins and arachidonic acid from one side of the laboring or non-laboring 
gestational membranes to the other.    McCoshen et al. (1987; 1990) mounted 8 cm2 discs 
of separated or intact gestational membranes in a dual-chamber perfusion device.  
Synthetic amniotic fluid was continuously circulated around the membranes.  
Experimental conditions were started after a 2 h pre-incubation period, and prostaglandin 
production and transport across labored or non-labored membranes was measured.   
The Vadillo-Ortega group from Mexico City was the first to use Transwell 
devices for gestational membrane culture (Zaga, Estrada-Gutierrez et al. 2004).  The 
main objective of their research was to study mechanisms responsible for preterm 
premature rupture of membranes.  They mounted membranes on the Transwell frame and 
secured them with silicone bands.  Culture medium included 10% fetal calf serum and 
membranes were incubated under standard tissue culture conditions for an equilibration 
period of 3 days before proceeding with the experiment.  This group measured cytokines 
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from the gestational membranes such as interleukin-1β and tumor necrosis factor-α after 
stimulation with bacteria or bacterial products.    
No research groups have optimized a system for studying independent side-
specific prostaglandin synthesis due to exogenous stimulus.  Furthermore, there has been 
no discussion of the inherent variability within the system.  The method described here 
addresses these limitations to allow for measurement of lipopolysaccharide (LPS) 
induced side-specific secretion of PGE2 and PGF2α (Chapter 3), LPS-induced side-
specific secretion of cytokines and cheomokines (Chapter 4) and 2,2',4,4',5,5'-
hexachlorobiphenyl induced side-specific secretion of PGE2 and PGF2α (Chapter 5). 
Because of the limitations of the previous methods for gestational membrane 
Transwell culture, further characterization and optimization of the method was needed 
before prostaglandin synthesis could be studied.  In particular, establishment of the in 
vitro Transwell culture of human gestational membranes required attainment of three 
goals: 1) optimization of specimen collection and transport to the laboratory, 2) 
optimization of culture and treatment conditions allowing discrete measurements of 
secreted prostaglandins and cytokines from the amnion and choriodecidua, and 3) 
determination of appropriate methods of analysis for data obtained. 
In addition to developing the gestational membrane Transwell culture, I explored 
several alternative techniques.  The Transwell culture method developed here has distinct 
advantages over monocellular isolation and culture, separated amnion and choriodecidual 
floating tissue cultures, and intact gestational membrane floating tissue cultures.  A brief 
review of the advantages and disadvantages of each technique are presented in the 
Results section of the Chapter.    
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MATERIALS AND METHODS 
Chemicals, Reagents and Antibodies 
Tissue culture reagents including high glucose Dulbecco’s Modified Eagle’s 
Medium (DMEM) without phenol red, penicillin/streptomycin antibiotic, and heat-
inactivated fetal bovine serum were purchased from Invitrogen (Carlsbad, CA).  
Lipopolysaccharide (LPS) from Salmonella Typhinurium (Lot #225) was purchased from 
List Biological Laboratory (Campbell, CA) and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 
153) was purchased from AccuStandard, Inc. (New Haven, CT).  The Vectastain Elite 
ABC immunohistochemical staining kit, DAB Substrate Kit (3,3’-diaminobenzidine) and 
hematoxylin counterstain were purchased from Vector Laboratories (Burlingame, CA). 
Prostaglandin E2 enzyme immunoassay kits were purchased from Cayman Chemical Co. 
(Ann Arbor, MI). Antibodies (anti-cyotokeratin 7 and anti-vimentin) were purchased 
from Dako North America, Inc. (Carpinteria, CA).   Transwell frames with no micropore 
membrane insert were a gift from Corning Corporation (Corning, NY).   
Tissue Acquisition 
Methods pertaining to human tissue were reviewed and approved by the local 
institutional review board prior to initiation of experiments; review and approval were 
updated yearly.  Full-thickness gestational membranes comprised of amnion, chorion and 
decidua were collected at 37-39 weeks from non-laboring elective Cesarean sections 
following healthy pregnancies. Exclusion criteria included smoking, multi-fetal gestation, 
complications of pregnancy such as gestational diabetes or hypertension, use anti-
inflammatory drugs (e.g., aspirin, Singulair®), or any other condition which would 
require the tissue to be sent to pathology.  Within 1-60 min after delivery, full-thickness 
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extraplacental membranes were sharp dissected from the placenta, placed in phosphate 
buffered saline solution and transported to the laboratory.  Alternatively, the entire 
placenta and attached membranes were transported to the laboratory. 
Tissue Culture 
In the laboratory, under sterile conditions, membranes were checked for integrity 
to ensure that amnion and choriodecidua remained attached to one another and that the 
collagen compact layer between the amnion and the choriodecidua was not degraded.  
The membranes were rinsed with culture medium (DMEM supplemented with 1% heat 
inactivated-fetal bovine serum and 100 units penicillan/100 μg streptomycin per 
milliliter) to remove excess blood clots.  The membranes were cut into approximately 2 x 
2 cm2 pieces (Fig. 2.1B) and affixed by latex rubber bands onto ethylene oxide sterilized 
Transwell frames (without a micropore membrane) to create two distinct chambers on 
either side of the mounted membranes (Fig. 2.1C-G) (Zaga, Estrada-Gutierrez et al. 
2004).  The choriodecidual side of the tissue faced the inner chamber of the device.  Extra 
tissue was removed with a scalpel.  Transwell frames with attached tissue were placed in 
12-well plates with culture medium on both sides of the membranes (Fig. 2.1H).  
Mounted membranes were cultured in a 5% CO2 tissue culture incubator for 2-4 h.  To 
maintain optimal culture conditions and health of the tissue, the medium was changed 
after the first equilibration period and then tissues were left overnight.  Prior to beginning 
the treatment protocol, the overnight culture medium was removed and the membranes 
were pretreated with fresh culture medium for 1-2 h.  Various culture conditions were 
tested to maintain optimal health of the tissue (see Results).  
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Treatment 
LPS was diluted in sterile deionized water to make a primary stock of 100 µg/ml.  
Just prior to the experiment, the LPS primary stock was further diluted with culture 
medium to achieve the experimental concentration (100 ng/ml).  To initiate exposure, 
medium was removed and fresh medium with or without LPS was added to the chambers 
of the culture dish, depending on the exposure conditions of the experiment. Mounted 
intact gestational membrane pieces were assigned randomly to treatment groups with 
three pieces of tissue included in each treatment.   Membranes were incubated with the 
treatments for 4 or 8 h.  After the specified treatment time, treatment medium was 
recovered from each side of the membrane and stored at -20°C or -80°C for subsequent 
enzyme immunoassay analysis of secreted PGE2.  The tissue was removed from the 
frame, weighed, embedded in freezing medium and frozen in tissue molds for subsequent 
immunohistochemistry analysis.   
Enzyme Immunoassay 
Prostaglandin E2 in the culture medium was assayed by enzyme immunoassay 
according to the manufacturer’s protocol (Cayman Chemical Co., Ann Arbor, MI).  Prior 
to the assay, samples were thawed and diluted to concentrations that fell within the range 
of the standard curve.  Each sample was assayed in duplicate.  PGE2 concentrations were 
calculated relative to the values from the standard curve.  Mean PGE2 concentrations 
were divided by the wet weight of gestational membrane tissue pieces and the mean of 
the treatment replicates was calculated.  Mean results and standard error of the mean 
were calculated from multiple subjects and graphed. Various methods for normalizing the 
data, decreasing variance and improving statistical power were tested (see Results). 
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Immunohistochemistry 
After tissue was removed from the Transwell frames, it was rolled, embedded in 
freeze medium, frozen in liquid nitrogen-cooled isopentane and stored at -80° C.  The 
tissue was sliced with a cryotome into 8 µm sections, and the cryosections were mounted 
on slides and stored at -80° C.  On the day of staining, slides were warmed to room 
temperature, fixed with 4% paraformaldehyde and stained using the Vectastain Elite 
ABC Kit according to the manufacturer’s protocol (Vector Labs).  Sections were 
incubated with primary antibodies (anti-cytokeratin 7 or anti-vimentin), labeled with a 
biotinylated secondary antibody and an avidin:biotinylated enzyme complex, visualized 
with 3,3-diaminobenzidine and counterstained with hematoxylin. Stained sections were 
visualized with an upright light microscope and recorded digitally. 
Statistical Analyses 
Intraclass correlation coefficients (ICC) were calculated to evaluate between-
subject variability compared to within-subject variability for tissues (amnion and 
choriodecidua) and treatment (non-treated control or lipopolysaccharide.)  Between-
subject and within-subject variance components were obtain using the PROC MIXED 
procedure (with 'covtest' option) in SAS 9.1 for Windows. 
RESULTS 
Tissue Acquisition  
Gestational membranes were collected from non-laboring healthy cesarean 
section deliveries at the University of Michigan Birth Center, with approval from the 
University of Michigan Institutional Review Board (IRB).  These cesarean deliveries 
were scheduled because of a previous cesarean or breech presentation of the baby, and 
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met the established exclusion criteria for our studies.  Because the tissue would normally 
have been discarded and no identifying patient information was linked with the collected 
specimens, requirement of informed consent was waived by the IRB.     
At the beginning of this project, we found that delays in specimen acquisition 
from the operating room resulted in degraded tissue and irregular in vitro tissue 
responses. Initially, operating room staff transported the specimen out of the operating 
room and we received the entire placenta with attached membranes after surgery was 
completed.  Because of variations in surgery time, we received the placenta and attached 
membranes 30 min to over 1 h after it was delivered.  During the intervening time 
between delivery and laboratory staff acquisition, blood associated with the placenta 
proper clotted on the membranes.  The blood clots along with the lack of moisture and 
oxygenation decreased the quality of the tissue for culture.   
To minimize these unwanted effects on the membranes, we worked with hospital 
staff to establish a more optimal procedure for obtaining the tissue.  Laboratory staff 
donned protective clothing and appropriate gear, and then waited within the surgical suite 
for the placenta with attached membranes to be delivered and placed in a sterile 
container.  Once the attending physician declared that the tissue did not need to be sent to 
pathology, the container was moved out of the surgical field and laboratory staff sharp 
dissected the extraplacental gestational membranes.  In most cases, the tissue was 
obtained almost immediately after delivery.  The gestational membranes were quickly 
placed in sterile, room temperature phosphate buffered saline solution for transport to the 
laboratory.  Tissue obtained in this manner had fewer blood clots and less overt 
histopathology, and yielded cultures with improved response to stimuli. 
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Establishment of Cultures  
In the laboratory, the health and integrity of the tissue was assessed by gross 
examination before samples were taken for tissue culture.  Criteria were established for 
tissue sampling from within a single specimen to ensure consistency across subjects and 
to minimize variability.  In particular, tissue samples were not taken from within 2 cm of 
the placenta or from any tissue showing signs of amnion and choriodecidual separation or 
degradation of collagen in the mesenchymal layer.  Additionally, tissue regions that were 
much thicker or thinner than the typical membranes were not used.  
Selected gestational membrane samples were mounted on Transwell frames.  
Initially, pre-sterilized Transwell devices were purchased from Corning.  These devices 
were designed by the manufacturer to be used for cellular co-cultures, and are 
commercially available with a micropore membrane insert attached to the frame.  Using 
the Transwell frames for the two-compartment gestational membrane tissue culture 
system required removal of the micropore membrane insert.  Later, we received 
Transwell frames that had no micropore membrane insert as a gift from Corning.  The 
Transwell frames were lightly sanded to enhance tissue attachment to the device and 
subsequently sterilized by ethylene oxide.  Membranes were attached to Transwell frames 
with sterile latex bands.   
Efforts were undertaken to ensure that the tissue remained healthy during culture 
for consistent prostaglandin measurements.  In particular, frequent media changes during 
the 18-24 h equilibration period improved tissue health.  In as little as 24 h in culture, the 
pH of the choriodecidual culture medium was 6.5, indicating that the tissue metabolism 
was exhausting the buffering capacity of the medium.   Time course experiments 
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indicated consistent prostaglandin secretion into culture medium under non-treated and 
LPS-stimulated conditions for up to 8 h of treatment (see chapter 3 for LPS time-course 
data).  However, little to no prostaglandins could be measured in culture medium after 24 
h.  Upon replacement of culture medium with fresh medium, these membranes resumed 
prostaglandin secretion.  The pH and prostaglandin time-course results suggested that 
accumulation of metabolites or depletion of nutrients in the medium was detrimental to 
the tissue and prostaglandin synthesis.  For these reasons, equilibration and treatment 
times were limited to 24 h or less. 
Immunohistochemistry 
Immunohistochemistry with anti-cytokeratin 7 or anti-vimentin antibodies 
identified specific cell types within fresh, intact gestational membrane tissue (Fig. 2.3).  
Amnion epithelial cells, mesenchymal fibroblast cells, and chorion trophoblast cells were 
identified by this method.  After equilibration and treatment periods, the health of the 
tissue was evaluated by immunohistochemistry (data not shown).  Tissue remained intact 
and morphologically healthy (similar to fresh, intact tissue in Fig. 2.3) after 18-24 h 
equilibration time and 1-24 h treatment time under control or stimulated treatment 
conditions. 
Variation of Prostaglandin Release  
Data from five subjects were used to assess variability in the model system.  
Prostaglandin E2 data from tissue exposed for 4 h to non-treated control conditions (NT) 
or 100 ng/ml LPS were analyzed.  In these experiments, secreted PGE2 response was 
measured in medium from the amnion or choriodecidual side of the Transwell by enzyme 
immunoassay.  The data were graphed and analyzed to assess the nature of variability  
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Plotting raw values for PGE2 release into amnion or choriodecidua media for each 
subject (duplicate or triplicate) revealed tissue-specific patterns of within-subject and 
between-subject variability (Fig. 2.4).  In the amnion (Fig. 2.4A), the within-subject 
variability was minimal, but the between-subject variability in response to LPS stimulus 
was large. For example, subjects 2 and 4 were high responders to LPS, subjects 1 and 3 
were medium responders to the stimulus, and subject 5 did not respond at all.  In 
comparison to amnion, the choriodecidua showed increased within-subject variability 
(Fig. 2.4B).  Furthermore, the choriodecidua response was not correlated with the amnion 
response.  For example, subject 5 produced no excess PGE2 in response to LPS treatment 
on the amnion side compared to the non-treated control samples, although this subject 
had a large PGE2 response on the choriodecidual side.   
To quantify within-subject and between-subject variability, intraclass correlation 
coefficients (ICC) were calculated.  The ICC can be estimated from the between-subject 
variance (σ2(b)) and the within-subject variance (σ2(w)): 
 ICC  =           σ2(b)      
     σ2(b) + σ2(w) 
 
Thus, the ICC is the ratio of the between-subject variance to the total variance.  As the 
ratio approaches 1, the variance is increasingly attributed to between-subject variance.  A 
lower ratio corresponds to higher within-subject variance relative to between-subject 
variance.  Table 2.1 shows the ICC calculated for the data from the five gestational 
membranes shown in Fig. 2.4.  The amnion NT value of 0.62 and the amnion LPS value 
of 0.97 indicated high between-subject variability compared to within-subject variability.  
In contrast, the choriodecidua NT value of 0.38 and the choriodecidua LPS value of 0.26 
indicated high within-subject variability for the tissue and treatment group.  This finding 
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correlates with the visual interpretation of Figure 2.4 and indicates distinct pathways 
within each tissue that determine response to LPS and distinct causes of variability. 
The same data plotted in Figure 2.4 were re-plotted as control or treatment means 
with the unit of analysis as the specimen (subject).  The overall scheme for this analysis 
is presented in Figure 2.5.  Three pieces of tissue from a single subject were exposed to 
the same treatment or control conditions.  PGE2 concentrations in media from each 
replicate were analyzed by enzyme immunoassay in duplicate.  Enzyme immunoassay 
means were calculated and further combined to calculate replicate means.  This overall 
mean was representative of the response from the subject and combined with results from 
other subjects with n referring to total number of subjects.   
Various methods of data adjustment were investigated to reduce within-subject 
and between-subject variability that may have arisen due to inconsistencies in sampling 
or culture methods.  Mean PGE2 concentrations for non-treated control (NT) and 
stimulated (LPS) conditions were graphed in Fig. 2.6A without adjustment.  An 
alternative approach was to graph the mean PGE2 concentrations from the EIA for each 
sample divided by the sample wet weight.  These values were then combined for all 
subjects and graphed to give the PGE2 produced per gram of tissue (Fig 2.6B).   This 
manipulation had little effect on the interpretation of the data or the between-subject 
variability.  In a second approach, the PGE2 per gram tissue values were normalized to 
non-treated control levels.  Within data from a single subject, mean PGE2 concentrations 
were divided by the mean PGE2 concentrations from the amnion non-treated control and 
multiplied by 100 to give percent non-treated control.  As can be seen in Fig. 2.6C the 
variability and statistical power were not improved by this manipulation.   
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 An alternative to the methods above was tested on samples from a single subject.  
Basal PGE2 secretion was measured on each of 4 control or treated (PCB 153) samples 
prior to the 4 and 24 h measurements. These data were then normalized to pretreatment 
concentrations (Fig. 2.7).  To do this, basal PGE2 concentrations were measured from the 
tissue during a pretreatment incubation (2 h).  Fresh control or treatment medium was 
applied to the tissue and collected after 4 h.  The treatment medium was then replenished 
and samples were incubated for an additional 20 h before the final medium collection.  
Raw PGE2 concentrations for basal, 4 and 24 hour time points are shown in Fig. 2.7A.  
To normalize to basal levels, PGE2 concentrations measured at 4 and 24 h from 
individual pieces of gestational membrane were divided by basal PGE2 concentrations 
from the same piece of membrane.  Means and standard error of the means were 
calculated for treated and non-treated control samples for each time point and graphed 
(Fig. 2.7B).  Dividing by basal PGE2 levels changed the relative values of some of the 
means.  However, no improvement was seen in the within-subject variability (Fig. 2.7). 
Alternative Culture Systems 
Alternative experimental designs and model systems to gestational membrane 
Transwell culture were considered to study prostaglandin response to stimulus in 
gestational membranes.  Primary cell monocultures of gestational membrane cell types 
including the amnion epithelium, mesenchymal fibroblast and chorion trophoblast cells 
were evaluated for studying the dynamics of prostaglandin synthesis and metabolism.  
Primary cell cultures have a number of drawbacks including being labor intensive due to 
the long isolation and purification procedures, cell yields that are insufficient for many of 
the experimental designs and poor culture purity and variability among subjects.  In 
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addition, the cell-to-cell or tissue-to-tissue interactions that occur in vivo are disrupted in 
cell cultures, yet may be important for shaping the prostaglandin response.  The 
alternative approach of using full-thickness gestational membranes in floating cultures 
was considered unsatisfactory because the amnion and choriodecidual contribution to the 
response cannot be differentiated.   
Another alternative is to separate the amnion from the choriodecidua by blunt 
dissection.  By analyzing the responses of separated membranes in floating tissue culture 
one may be able to discern tissue-specific sensitivity and response to a stimulus.  
However, I found that the amnion folded up on itself in culture, leading to variable and 
suboptimal culture conditions.  In addition, immunohistochemical analysis of the post-
culture tissue indicated that the amnion epithelium of separated tissue degraded in 
culture.  Furthermore, the blunt dissection of amnion and choriodecidua may produce 
erroneous results if the chorion mesenchyme partitions with the amnion, and if the 
intermediate collagen layer is distributed unevenly to either the amnion or chorion side 
(Fig 2.8). Furthermore, this experimental model does not allow exploration of amnion 
and choriodecidual interactions or the ability of amniotic prostaglandins to pass or signal 
through the choriodecidua. 
DISCUSSION 
Because of significant differences between species in pregnancy implantation, 
placentation and parturition, there are no satisfactory animal models for research on 
mechanisms of human parturition.  Fortunately, human placentas and gestational 
membranes are normally discarded and thus, can be relatively easily obtained for 
research purposes.  In this work, I have optimized methods to make use of this tissue to 
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develop the gestational membrane Transwell system for studying gestational membrane 
responses to exogenous stimuli (Fig 2.9).  This system was designed to address 
unanswered questions about prostaglandin production in the gestational membranes.   
Previously, two laboratories published research using a Transwell gestational 
membrane model or a similarly principled model.  Early attempts were undertaken to 
culture gestational membranes in a dual chamber system and study differences in 
prostaglandin release under laboring or non-laboring conditions (Nakla, Skinner et al. 
1986; McCoshen, Johnson et al. 1987).  More recently, a group in Mexico City headed by 
Vadillo-Ortega has expanded and improved upon the model.  The culture system 
described here is based on the model of Vadillo-Ortega (Zaga, Estrada-Gutierrez et al. 
2004).  Previous research in this field did not take into account differences in response to 
stimulation of the amnion and choriodecidua sides of the gestational membranes.  The 
system I describe in this work addresses this important gap.   
I have refined the technique established by the Vadillo-Ortega group to optimize 
for prostaglandin measurements.  In contrast to their practice of equilibrating gestational 
membrane Transwell cultures for 3 days prior to exposing to experimental conditions, I 
equilibrated the explant cultures for 18-24 h. Their report that it took 3 days for the tissue 
to regain health and integrity after commencing the culture was not supported by my 
data.   Instead, I found that the health of the tissue decreased over time in culture.  The 
decrease in pH over 24 h combined with gross examination of the tissue and IHC results 
led to our practice of conducting the experiment as quickly as possible after a reasonable 
recovery period.  Our goal was to keep the tissue as healthy as possible while reducing 
the number of changes and adaptations the tissue makes in culture.  During the 18-24 h 
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equilibration period, the medium was changed twice to maintain correct pH of the 
medium. Experimental treatments of 1-24 h were conducted following the equilibration 
period.  Although we cannot mimic a pregnant uterus in culture, this system maintains the 
tissue in a physiologic state that more closely resembles that of pregnancy.  
Another difference in culture practices from the Vadillo-Ortego group is our use 
of 1% heat inactivated fetal bovine serum (FBS) for the duration of the experiment 
compared to their use of 10% FBS during the equilibration period and no FBS during the 
experimental period (Zaga, Estrada-Gutierrez et al. 2004). Using 1% FBS allowed for 
continuity of culture medium between equilibration and treatment periods. 
At the onset of this project, it became clear that though there were many 
advantages to working with this tissue in lieu of animal models, there were also some 
disadvantages.  The foremost concern was the high variability seen in the prostaglandin 
response to stimuli (Fig. 2.4) that made it difficult to draw meaningful conclusions about 
the data.  We needed to determine whether variability was due to sampling and culture 
methodology or due to biological differences in samples from different subjects or from 
different regions of the membranes from a single subject.   
There are meaningful explanations for a portion of the variability.  High between-
subject variability may be related to the genetics of the mother or the baby as well as the 
environment to which they are exposed.  Between-subject variability may be due to 
proximity to the onset of labor.  There is certain to be biochemical differences in tissues 
taken from subjects that may have been within hours of the onset of natural labor 
compared to others may not have delivered for weeks.  This notion is corroborated by 
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research reporting increased cytokine response to LPS stimulus from early gestational 
age samples compared to term gestational age samples (Jung, Yoon et al. 2005). 
It is interesting to note that the within-subject variability differs from samples 
taken from the amnion side compared to the choriodecidua side of the same piece of 
tissue.  This could be due to culture conditions or to inherent differences in the tissue.  
Overall, the amnion had a more uniform response to stimulus.  High variability in pieces 
of choriodecidua from one subject may be due to placement within the uterus.  For 
example, choriodecidua that is near a cervix undergoing dilation and effacement may 
respond differently to LPS stimulation than choriodecidua adjacent to the upper fundus 
which undergoes tonic uterine contractions to expulse the fetus.  Though variability in the 
tissue is frustrating for certain experimental designs, differences in choriodecidual 
responses from various places within the uterus may be physiologically important for 
understanding of the interactions between decidua and myometrium during labor. 
There has been no discussion in the scientific literature of methods to deal with 
inherent variability of prostaglandin production in gestational membrane tissues.  This 
work is the first to examine the variability of human gestational membranes, investigating 
how different data manipulations affect this variability.  Neither normalizing the 
stimulated values to non-treated control values (Fig. 2.6C) nor normalizing to 
pretreatment prostaglandin values (Fig. 2.7) improved the variability.  Given the 
inadequacy of these approaches, we decided that the simple normalization to tissue wet 
weight was the best approach.  This approach was likely more precise than normalizing 
to surface area as previously used (Zaga, Estrada-Gutierrez et al. 2004) since mass 
measurements on an analytical balance are more precise than surface area measurements.   
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 Compared to cellular isolations or other forms of tissue culture, the gestational 
membrane Transwell system is most adept at understanding dynamics of side-specific 
prostaglandin secretion in response to stimulus.  Alternative in vitro systems, such as 
intact and separated floating gestational membrane cultures, have been used to study 
stimulated responses of human gestational membranes.  However, each of these 
approaches is limited in the ability to differentiate the side of the tissue that secretes 
prostaglandins.  An immeasurable benefit of the Transwell system is the ability to 
maintain cell-to-cell and tissue-to-tissue interactions that may be important for processing 
inflammatory signals while detecting side-specific production of prostaglandin species.  
Gestational membrane Transwell experiments will be useful for determining under what 
conditions prostaglandins are released from choriodecidua side of the membranes with 
potential to modulate uterine contractions and parturition. 
Research on the role of gestational membranes in parturition is at an early stage.  
Most previous research has utilized isolated cell cultures or floating gestational 
membrane explant cultures to focus on differences in cells and tissue before and after 
parturition.   Additionally, cell and tissue prostaglandin responses to LPS or bacterial 
stimulation have been demonstrated but without the context of the intact gestational 
membrane side-specific prostaglandin output could not be determined.  The development 
of the gestational membrane Transwell system allows new research to explore the 
mechanisms of prostaglandin dynamics in the gestational membranes through 
measurement of side-specific tissue responses. 
This system can be used to study release of various factors, such as cytokines, and 
is amenable to a wide variety of stimulants.  The present study characterized the system 
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using the model inflammatory stimulant LPS, but experiments have also been conducted 
in our laboratory with environmental toxicants such as polychlorinated biphenyls, 
polybrominated diphenyl ethers, and phthalate metabolites.  Other possibilities for study 
in this system include signal transduction, nutrient transport or the mechanisms by which 
the membrane functions as a barrier to infectious disease.   
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Figure 2.1.  Diagram of gestational membrane mounted on Transwell frame.  The 
choriodecidual side of the membrane faces the inner chamber and the amniotic side of the 
membrane faces the outer chamber.  This design allows for discrete stimulation and 






Figure 2.2.  Step-by-step process of mounting full-thickness gestational membranes 
on Transwell frames.  A) Gestational membrane tissue after sharp dissection from the 
placenta proper.  Excessive blood clots or regions where membranes are coming apart or 
disintegrating are removed before selecting samples for culture.  B) Gestational 
membrane samples of 2 cm x 2 cm were cut off of the main specimen and floated in 
culture medium.  C) One sample was placed on top of a sanded, sterilized Transwell 
device. D) Gestational membranes were affixed to the Transwell device with sterilized 
latex bands.  E)  Excess membranes were removed with a scalpel leaving no membranes 
free beneath the latex band.  F) One gestational membrane affixed to a Transwell device.  
G)  Transwell devices with affixed gestational membranes in culture medium.  H)  
Gestational membranes on Transwell devices are cultured in 24-well plates with medium 













Figure 2.3.  Immunohistochemical staining of intact gestational membranes. 
A.) Cryosections of  intact, fresh gestational membranes were stained with anti-
vimentin antibodies.  B.) Cryosection of intact, fresh gestational membranes were 
stained with anti-cytokeratin 7 antibodies.  In both panels sections were 
counterstained with hematoxylin (blue) to identify specific cell types and study 
health and integrity of the tissue.  A single layer of amnion epithelial cells (AE) 
stain blue (hematoxylin) in both panels.  Decidual cells (D) and fibroblast cells of 
the mesenchymal layer (M) stain positively (brown) for vimentin but not 
cytokeratin 7.  Chorion trophoblast cells (CT) stain positively for cytokeratin 7 







































Figure 2.4. Graphs depicting within-subject and between-subject variability.  
Gestational membranes mounted Transwell frames were exposed for 4 h to 100 
ng/ml lipopolysaccharide (LPS) on both sides of the membrane to assess 
variability in prostaglandin response to treatment.  PGE2 concentrations from (A) 
amnion culture medium or (B) choriodecidual culture medium were analyzed.  
For each subject (designated by a number on the x-axis), LPS-treated (red square) 
or non-treated control (NT, blue circle) replicates were graphed.  Means for NT 
and LPS-treated PGE2 values are indicated by a bar of the corresponding color.  
Each subject had two or three replicates per treatment; subject numbers in (A) 
correspond to those in (B).  
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Table 2.1.  Interclass correlation coefficient 
 non-treated control LPS 
amnion 0.62 0.97 
choriodecidua 0.38 0.26 
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Figure 2.5.  Diagram of Transwell analysis scheme.  From each subject, three 
pieces of gestational membrane were exposed to each treatment.  In the simplified 
design shown here, there were two treatment groups: non-treated control (NT) and 
LPS-exposed.  Prostaglandin values in medium from the amnion and 
choriodecidual chambers of the cultures for each treatment replicate were 
analyzed separately by enzyme immunoassay in duplicate.  Means from analysis 
duplicates were averaged, and then treatment replicate means for each 
specimen/subject were calculated.  Means from each specimen/subject were 
combined into one value making the unit of analysis the specimen/subject.
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 Figure 2.6.  Comparison of non-treated control- (NT) and lipopolysaccharide- 
(LPS) stimulated PGE2 graphs after different methods of data processing.  A) PGE2 
concentrations (pg/ml) measured in from culture medium on amnion or choriodecidual 
sides of gestational membrane.  Mean concentrations from 5 subjects ± standard error of 
the mean are graphed.  B)  Graph of amnion or choriodecidual PGE2 concentrations per 
sample divided by wet tissue weight of that sample (pg/ml/g wet tissue).  Treatment or 
control mean concentrations per gram wet tissue were calculated for each subject and 
combined with data from other subjects to graph mean results from 5 subjects ± standard 
error of the mean.  C) PGE2 concentrations per gram wet tissue from each subject were 
normalized to percent amnion non-treated control (% A-NT) from the same subject and 
combined with values from other subjects.  Values are expressed as mean % A-NT for 5 























































































































































































































Figure 2.7.  Comparison of raw PGE2 concentrations and data expressed as a ratio 
of treatment to basal PGE2 levels.  A) Mean PGE2 concentrations (pg/ml) from amnion 
or choriodecidual chambers during 2 h basal period (dark and light blue) and 4 and 24 h 
non-treated control or PCB 153 treatment periods (black and white).  B) 4- and 24-h 
treatment PGE2 concentrations normalized to basal PGE2 concentrations from the same 












Figure 2.8.  Hematoxylin stained cryosections of amnion and choriodecidua after 
blunt dissection of gestational membrane tissue.  A) Amnion epithelium (AE) was 
degraded after blunt dissection.  Amnion mesenchyme (AM) and chorion mesenchyme 
(CM) partition with amnion layer.  B) After blunt dissection of gestational membranes 












Figure 2.9.  Model of the gestational membrane Transwell system.  Mounting 
gestational membranes for tissue culture allows the researcher to stimulate the amnion or 
choriodecidual sides of the membrane independently.  It also allows independent 
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LIPOPOLYSACCHARIDE-INDUCED PROSTAGLANDIN SECRETION FROM 
HUMAN GESTATIONAL MEMBRANE TRANSWELL CULTURES 
 
ABSTRACT 
In women, uterotonic prostaglandins from gestational membranes play an 
important role in uterine contractility and cervical effacement during parturition.  Prior to 
term, exogenous inflammatory conditions such as infection and the subsequent increased 
production of prostaglandins may cause contractions and lead to preterm delivery of the 
baby, a significant public health concern.  The purpose of this research is to investigate 
the side-specific prostaglandin secretion from the amnion (fetal) and choriodecidual 
(maternal) sides of intact human gestational membranes after exposure to the 
inflammatory stimulus lipopolysaccharide (LPS), a component of bacteria cell 
membranes.   Pieces of gestational membranes from healthy, non-laboring cesarean 
deliveries were mounted on Transwell frames and exposed to LPS on one or both sides of 
the membrane.   Lipopolysaccharide-stimulated prostaglandin E  (PGE )2 2  and 
prostaglandin F  (PGF2α 2α) were measured in the medium of the amnion and 
choriodecidual sides of the membranes.  More PGE2 was produced on the amnion side 
whereas PGF2α was secreted to a similar extent from both sides of the gestational 
membranes.  Side-specific differences for LPS-stimulated concentration-response and 
time-course release of prostaglandins indicated relative independence of the amnion and 
choriodecidua responses to LPS stimulation.  Immunohistochemistry revealed LPS-
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dependent and side-specific expression of the rate-limiting enzyme in prostaglandin 
synthesis, prostaglandin endoperoxide H synthase-2 (PGHS-2).  Induction of PGHS-2 
was seen on the side of the tissue exposed to LPS treatment.  LPS exposure to the amnion 
side caused PGHS-2 induction in cells of the sub-amniotic mesenchymal layer, and LPS 
exposure to the choriodecidual side caused PGHS-2 induction in decidual cells.  When 
both sides of the membranes were exposed to LPS, PGHS-2 induction was seen in the 
mesenchymal and decidual layers of the tissue.  Results presented here suggest that LPS 
induction of PGHS-2 leads to increased prostaglandin secretion from both sides of the 
gestational membranes.   
INTRODUCTION 
Extraplacental human gestational membranes are comprised of amnion, chorion 
and decidua.  In situ, the amnion faces the fetal compartment while the decidua is 
interdigitated with the uterine wall.  The gestational membranes make prostaglandins 
during human pregnancy.  Close proximity to the myometrium may allow prostaglandins 
from gestational membranes to play an important role in parturition.  The uterotonic 
prostaglandins, PGE  and PGF2 2α, are of particular interest because they are potent 
stimulators of myometrial contractility and are elevated in women experiencing preterm 
and term labor (Munns, King et al. 1999).   
In contractility experiments with pregnant rat uterine strips, we found that an 
intact uterine lining was required to elicit increased force and frequency of contractions 
in response to 2,2',4,6-tetrachlorobiphenyl (PCB 50) (Brant and Caruso 2006).  This 
finding led us to speculate that prostaglandin synthesis in the uterine lining (decidua in 
human pregnancies) may be responsible for increased myometrial contractility during 
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exposure to toxicants and inflammatory stimuli. Previous studies demonstrated increased 
prostaglandin secretion from human gestational membranes obtained after normal vaginal 
delivery compared to scheduled, non-laboring Cesarean section delivery (Mijovic, Zakar 
et al. 1997).  Researchers hypothesize that preterm uterine contractility and parturition are 
caused by preterm gestational membrane prostaglandin production due to exogenous 
inflammatory stimuli (Van Meir, Sangha et al. 1996).   
Prostaglandins are derived from arachidonic acid, which is released from 
phospholipids in the cell membrane by phospholipases.  Arachidonic acid is converted to 
prostaglandin H by prostaglandin endoperoxide H synthase (PGHS).  Prostaglandin H 
synthase-2, also known as cyclooxygenase-2 or COX-2, is the inducible isoform of the 
enzyme.  It is induced in human gestational tissues at the time of parturition, and is 
responsible for the increased prostaglandin formation seen near term (Gibb and Sun 
1996).  Prostaglandin endoperoxide H synthase-2 is also induced in response to 
inflammatory agents.  Prostaglandin H is converted to PGE  or PGF2 2α by prostaglandin E 
synthase or prostaglandin F synthase, respectively (Sales and Jabbour 2003).  Cell and 
tissue specific localization of synthase enzymes may determine which prostaglandin 
species are produced.  Traditionally, PGE2 synthesis has been thought to occur 
throughout the extraplacental gestational membranes with high levels of synthase activity 
in the amnion while PGF2α synthesis is located in the decidua (Okazaki, Casey et al. 
1981). The enzymes in the prostaglandin pathway are subject to a variety of regulatory 
mechanisms from hormones, cytokines, and growth factors.  
Prostaglandin catabolism is rapid and prostaglandin isomers are inactivated by 15-
hydroxy-prostaglandin dehydrogenase (PGDH).  Some reports indicate that PGDH 
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activity is reduced in term or preterm labor, and researchers hypothesize that the 
localization of PGDH in chorionic trophoblasts creates a metabolic barrier preventing 
passage of prostaglandins from the amnion to the underlying myometrium (Challis, Lye 
et al. 2001).   
Intrauterine infection is thought to be the single most causative factor in the 
etiology of preterm labor and birth in humans, accounting for as many as one-third of all 
preterm deliveries (Goldenberg, Culhane et al. 2008).  Lipopolysaccharide (LPS) is a cell 
membrane component from gram negative bacteria that elicits a strong immune response 
and may be an important signaling molecule in these cases of intrauterine infection and 
preterm birth.  It is commonly used as a model inflammatory agent.  In mouse models of 
preterm labor and birth, injection of LPS into the cervix causes preterm expulsion of the 
fetuses (Reznikov, Fantuzzi et al. 1999).   
Lipopolysaccharide induces prostaglandin synthesis by inducing enzymes of the 
prostaglandin synthetic pathway, particularly PGHS-2 (Brown, Alvi et al. 1998).  It may 
also indirectly affect prostaglandin production by inducing production of inflammatory 
cytokines such as tumor necrosis factor-α (Sato, Keelan et al. 2003).   
The goal of this research was to investigate the side-specific prostaglandin 
secretion from intact gestational membranes exposed to the inflammatory stimulus, LPS.  
This was modeled in our laboratory by LPS treatment of membranes mounted on 
Transwell devices followed by measurement of prostaglandins in amnion or 
choriodecidual culture medium and immunohistochemical analysis of PGHS-2 induction.  
Better knowledge of prostaglandin production in non-laboring gestational membranes 
will enhance our understanding of preterm labor or other complications of parturition.  
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Exposure to exogenous stimuli such as LPS may activate prostaglandin signaling 
prematurely.   
MATERIALS AND METHODS 
 Chemicals, Reagents and Antibodies 
Tissue culture reagents including high glucose Dulbecco’s Modified Eagle’s 
Medium (DMEM) with no phenol red, penicillin/streptomycin antibiotic, and heat-
inactivated fetal bovine serum were purchased from Invitrogen (Carlsbad, CA).  
Lipopolysaccharide (LPS) from Salmonella Typhinurium (Lot #225) was purchased from 
List Biological Laboratory (Campbell, CA).  The Vectastain Elite ABC 
immunohistochemical staining kit, DAB Substrate Kit (3,3’-diaminobenzidine) and 
hematoxylin counterstain were purchased from Vector Laboratories (Burlingame, CA). 
Prostaglandin E  and prostaglandin F2 2α enzyme immunoassay kits and anti-
cyclooxygenase monoclonal antibody were purchased from Cayman Chemical Co. (Ann 
Arbor, MI). Transwell frames with no micropore membrane insert were a gift from 
Corning Corporation (Corning, NY).   
Tissue Collection 
Methods pertaining to human tissue were reviewed and approved by the local 
Institutional Review Board prior to initiation of experiments; review and approval were 
updated yearly.  Full-thickness gestational membranes comprised of amnion, chorion and 
decidua were collected at 37-39 weeks from non-laboring elective Cesarean sections 
following healthy pregnancies. Exclusion criteria included smoking, multiple fetal 
gestation, complications of pregnancy such as gestational diabetes or hypertension, use of 
drugs that may have an effect on arachidonic acid metabolism (e.g., aspirin, Singulair®), 
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or any other condition which would require the tissue to be sent to Pathology.  Within 1-
60 min after delivery, full-thickness extraplacental membranes were sharp dissected from 
the placenta, placed in phosphate buffered saline solution and transported to the 
laboratory.  Alternatively, the entire placenta and attached membranes were transported 
to the laboratory. 
Tissue Culture 
In the laboratory, the integrity of the membranes was examined under sterile 
conditions to verify that the amnion and choriodecidua remained attached to one another 
and that the collagen compact layer between them was not degraded.  The membranes 
were rinsed with culture medium (DMEM supplemented with 1% heat inactivated-fetal 
bovine serum and 100 units penicillin/100 μg streptomycin per milliliter) to remove 
excess blood clots.  The membranes were cut into approximately 2 x 2 cm2 pieces and 
affixed by latex rubber bands onto ethylene oxide sterilized Transwell frames without a 
micropore membrane insert (Zaga, Estrada-Gutierrez et al. 2004).  The choriodecidual 
side of the tissue faced the inner chamber of the device.  Extra tissue was removed with a 
scalpel.  Each Transwell frame with attached tissue was placed in a single well of a 12-
well plate with culture medium on both sides of the membranes, creating two distinct 
chambers on either side of the membrane.  Mounted membranes were equilibrated in a 
5% CO2 tissue culture incubator.  To maintain optimal culture conditions and health of 
the tissue, membranes in culture medium were equilibrated for 18-24 h with a medium 
change after 2-4 h.  Prior to beginning the treatment protocol, the overnight culture 
medium was removed and the membranes were pretreated with fresh culture medium for 
1-2 h.  
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Treatment 
The LPS was diluted in water to make a primary stock of 100 µg/ml.  Just prior to 
the experiment, the LPS primary stock was further diluted with culture medium (DMEM 
supplemented with 1% heat inactivated-fetal bovine serum and 100 units penicillin/100 
μg streptomycin per milliliter) to achieve the experimental concentration (1-1000 ng/ml, 
as indicated), and added to one or both chambers of the culture. In cases where only one 
side of the membranes was treated with LPS, the opposite side was cultured in culture 
medium.  Mounted full-thickness gestational membrane pieces collected from different 
regions of the membranes were assigned randomly to treatment groups.  Treatments were 
conducted in triplicate, i.e., three pieces of tissue were included in each treatment.  
Membranes were incubated with the treatments for 1-24 h.  After the specified treatment 
time, treatment medium was recovered from each side of the membrane and stored at -
20°C or -80°C for subsequent enzyme immunoassay analysis of PGE2 and PGF2α.  The 
tissue was removed from the Transwell device, weighed, embedded in freezing medium 
and frozen in tissue molds for subsequent immunohistochemistry analysis.   
Enzyme Immunoassay 
Prostaglandin E  and PGF2 2α in the culture medium were assayed by specific 
enzyme immunoassays according to the manufacturer’s protocol (Cayman Chemical Co., 
Ann Arbor, MI).  Prior to the assay, samples were thawed and diluted to fall within the 
range of the standard curve.  Each medium sample was assayed in duplicate.  PGE2 
concentrations were calculated relative to the values from the standard curve.  
Prostaglandin concentrations were divided by the wet weight of the full-thickness 
gestational membrane tissue taken after the experiment, and the mean of the treatment 
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replicates was calculated.  An overall mean for each specimen was calculated and 
combined with results from other specimens.  Mean results and standard error of the 
mean were calculated from multiple specimens and graphed with n referring to the 
number of specimens (subjects) in each experiment. 
Immunohistochemistry 
After tissue was removed from the Transwell frames, it was rolled, embedded in 
freeze medium, frozen in liquid nitrogen-cooled isopentane and stored at -80° C.  The 
tissue was sliced with a cryotome into 8 µm sections, the cryosections were mounted on 
slides and stored at -80° C.  On the day of staining, slides were warmed to room 
temperature, fixed with 4% paraformaldehyde and stained using the Vectastain Elite 
ABC Kit.  Sections were incubated with primary antibody (anti-PGHS-2 monoclonal 
antibody), labeled with a biotinylated secondary antibody and an avidin:biotinylated 
enzyme complex, developed with 3,3-diaminobenzidine and counterstained with 
hematoxylin. Stained sections were visualized with an upright light microscope and 
recorded digitally. 
Statistical Analyses 
The prostaglandin enzyme immunoassay results were analyzed by one-way or 
two-way analysis of variance (ANOVA) using Sigma Stat v 3.5 software (Systat 
Software, Inc., Richmond, CA).  Prior to analysis, the data were transformed using log 
normal transformation to correct for non-normality.  Post hoc pair-wise comparisons of 
means were performed by the Student-Newman-Keuls methods.  A p-value <0.05 was 
considered statistically significant.   
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RESULTS 
Concentration-response of LPS-stimulated prostaglandin E  release 2
To study LPS-dependent concentration effects on PGE2 release from gestational 
membrane Transwell cultures, PGE2 secretion was measured in amnion and 
choriodecidua culture media after an 8-h exposure to 1, 10, 100 or 1000 ng/ml LPS or 
non-treated control (NT) (Fig. 3.1).  The basal concentration of PGE2 in the amnion NT 
media was 1601 pg/ml/g after 8 h of culture. In the amnion medium, near maximal PGE2 
concentration (13507 pg/ml/g) was observed with 1 ng/ml LPS exposure, the lowest 
concentration of LPS tested.  Amnion PGE2 responses to 10, 100 and 1000 ng/ml LPS 
were similar to the 1 ng/ml response with concentrations of 12495, 11660, and 11229 
pg/ml/g, respectively.  High variability in the amnion response precluded a statistically 
significant difference between LPS treatments and controls. 
The choriodecidual non-treated control PGE2 concentration after 8 h of culture 
was 509 pg/ml/g.  In the choriodecidual culture medium, concentrations of PGE2 
increased modestly with increasing LPS treatment concentration, such that PGE2 
concentrations of 3717, 4699, 5200 and 5863 pg/ml/g were observed for 1, 10, 100 and 
1000 ng/ml LPS treatment, respectively.  All choriodecidual LPS-stimulated PGE2 
concentrations were significantly increased compared with non-treated control samples 
(p<0.05), but were not significantly different from each other.   
The concentration-response experiment indicated that LPS stimulated PGE2 
release at 1 ng LPS/ml, the lowest concentration tested.   There was no significant 
additional PGE2 response with increasing LPS treatment concentration for either the 
amnion or choriodecidual side, suggesting a threshold effect.   
 55
Time-course of LPS-stimulated prostaglandin E  release  2
Tissues were incubated for 1-24 h to analyze the dynamics of gestational 
membrane PGE  concentrations in media in response to LPS.  Secreted PGE2 2 was 
measured by enzyme immunoassay in culture medium taken from the amnion (Fig. 3.2A) 
or choriodecidual sides (Fig. 3.2B) of the gestational membrane Transwell culture after 1, 
4, 8 or 24 h exposure to 100 ng/ml LPS.   
Prostaglandin E2 concentrations in amnion medium from NT samples increased 
slightly over 1 to 8 h of exposure with mean concentrations of 261, 815 and 1051 pg/ml/g 
tissue for 1, 4 and 8 h, respectively (Fig. 3.2A, left side).  Mean PGE2 concentrations 
from 4- and 8 h- amnion NT culture media were significantly higher than 1-h levels 
(p<0.05).  Prostaglandin E2 concentrations decreased in 24-h culture medium to 441 
pg/ml/g, which was not statistically significantly different from concentrations observed 
at 1 h.   
LPS-stimulated prostaglandin E2 production increased over time in the amnion 
medium. Mean concentrations of 1461, 4157 and 10029 pg/ml/g tissue for 1, 4 and 8 h 
exposures, respectively, were significantly increased compared with non-treated controls 
of the same exposure duration  (Fig. 3.2A, right side; p<0.05).  Little PGE2 was measured 
in the amnion medium after 24 h of LPS exposure (575 pg/ml/g), and the mean PGE2 
concentration from 24 h LPS exposed tissue was significantly different from 8 h levels 
(p<0.05).   
Concentrations of PGE2 in the choriodecidual culture medium of controls (NT) 
were not statistically significantly different from each other at 1, 4, 8 and 24 h of culture, 
respectively (Fig. 3.2B, left side).  LPS stimulated PGE  release from the choriodecidual 2
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side of the membranes, with values of 2956, 2744, and 3105 pg/ml/g measured at the 1, 4 
and 8 h LPS-treatment time points, respectively (Fig. 3.2B, right side).  Mean PGE2 
concentrations from 1, 4 and 8 h LPS-treated samples were significantly greater than the 
mean PGE  concentrations from the 24-h time point (333 pg/ml/g) (p<0.05).   2
The rate of PGE2 response to LPS stimulation is different between the amnion and 
choriodecidual sides of the membranes.  The peak PGE2 response is observed later in the 
amnion (8 h) compared to choriodecidua.  In both amnion and choriodecidual culture 
media, little PGE2 was recovered in the non-treated control or LPS-treated samples after 
24 h of exposure, indicating that PGE2 ceases to be synthesized beyond 8 h of stimulation 
and suggesting that PGE2 from earlier in the exposure may be degraded in the culture 
medium or taken up by the tissue.  Future experiments were conducted with an 8-h LPS 
exposure time to capture peak LPS-stimulated prostaglandin production. 
PGE  and PGF2 2α response to side-specific LPS treatment of gestational membranes 
Prostaglandin release was assessed from the amnion and choriodecidual sides of 
intact gestational membranes cultured on Transwell devices treated with LPS in a side-
specific manner.  Membranes were treated for 8 h with 100 ng/ml LPS on only the 
amnion side of the membranes, only the choriodecidual side of the membranes, both 
sides of the membranes or neither side of the membranes (non-treated control).  In cases 
where only one side of the membranes was treated with LPS, the other side was 
incubated with culture medium (DMEM plus 1% FBS and antibiotics).  Prostaglandin E2 
(Fig. 3.3A) and PGF2α (Fig. 3.3B) were measured in the culture media on both the 
amnion and choriodecidual sides of the membrane after an 8-h exposure.   
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All forms of LPS treatment resulted in statistically significant amniotic PGE2 
response compared to non-treated control samples (p<0.05; Fig. 3.3A).  Moreover, the 
amnion produced significantly more PGE2 than the choriodecidua side of the membranes 
under all LPS-treated conditions.  When only the amnion side was treated with LPS, there 
was a robust PGE2 response on the amnion side (13370 pg/ml/g; p<0.05) but not the 
choriodecidual side (609 pg/ml/g).  However, when only the choriodecidual side was 
treated, the amnion PGE2 response remained significantly greater than the choriodecidua 
response (7582 pg/ml/g vs.1398 pg/ml/g; p<0.05).  Similarly, when both sides of the 
membrane were treated with LPS, the mean amnion PGE2 response was greater than the 
choriodecidual response (13040 vs. 4773 pg/ml/g; p<0.05), indicating that no additional 
increase in amnion PGE  response was gained from treating both sides of the membrane.   2
Though choriodecidua PGE2 concentrations were lower overall compared to the 
amnion, there remained a statistically significant increase in choriodecidual PGE2 
concentrations from samples treated with LPS on the choriodecidual side only (1398 
pg/ml/g) and samples treated with LPS on both sides (4173 pg/ml/g) compared to non-
treated control samples (358 pg/ml/g) (p<0.05).  PGE2 from choriodecidual samples 
treated with LPS on both sides of the membrane was significantly higher than from 
samples treated on only the amnion side of the membrane, also (p<0.05).   
In contrast to the side-specific PGE  results, PGF2 2α  response to LPS treatment 
was comparable in medium from both sides of the membranes (Fig. 3B).  Mean PGF2α 
concentrations in amnion culture medium from samples treated on the amnion, 
choriodecidual or both sides of the membranes were 3789, 2663, and 5604 pg/ml/g, 
respectively, and were significantly increased relative to non-treated control samples (525 
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pg/ml/g) (p<0.05).  In the choriodecidual culture medium, mean PGF2α concentrations 
were increased in samples treated on the choriodecidual or both sides of the membrane 
(7547 and 10698 pg/ml/g) compared to non-treated controls (1587 pg/ml/g) (p<0.05).   
Gestational membrane prostaglandin endoperoxide H synthase-2 
immunohistochemistry from side-specific LPS treatments 
Immunohistochemistry was used to investigate whether LPS-induced changes in 
prostaglandin secretion from gestational membranes were related to changes in 
expression of prostaglandin H synthase 2 (PGHS-2).  After medium was collected for the 
LPS-stimulated prostaglandin release experiments described above, the gestational 
membranes were removed from the Transwell devices, fixed, cryosectioned and 
immunostained for PGHS-2 (Fig. 3.4).   
No positive PGHS-2 staining was seen in amnion, chorion or decidua of the non-
treated control samples (Fig. 3.4A and B). In tissue treated with LPS on the amnion side 
only, trophoblast cells in the amnion and chorion mesenchymal region stained positive 
for PGHS-2 (Fig 3.4C), but no positive PGHS-2 staining was seen in the decidua (Fig. 
3.4D). In tissue treated with LPS on the choriodecidual side only, PGHS-2 was detected 
in cells in the decidua (Fig. 3.4F), but cells in the amnion and chorion did not stain 
positive for PGHS-2 (Fig. 3.4E).  In tissue treated with LPS on both sides of the 
membranes, cells in both the amnion and chorion mesenchymal region and the decidua 
stained positive for PGHS-2 (Fig. 3.4G and H).   
DISCUSSION 
The Transwell experimental model used in the present study allowed side-specific 
LPS stimulation of intact gestational membranes and side-specific measurement of 
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prostaglandin response.  Differentiating the sources of prostaglandins released in 
response to LPS in non-laboring gestational membranes may help clarify the role of 
inflammation- or infection-stimulated prostaglandins in events related to preterm 
parturition.   
Side-specific LPS exposures revealed an increase in prostaglandin release on the 
amnion side but not the choriodecidual side of the membranes when only the amnion side 
was exposed to LPS.  In tissue from these experiments, detection of immunoreactive 
PGHS-2 in the mesenchymal fibroblasts suggested that mesenchymal PGHS-2 induction 
may be responsible for amniotic prostaglandin response.  When only the choriodecidual 
side was exposed to LPS, PGE  and PGF2 2α were secreted into the choriodecidual culture 
medium correlating with appearance of immunoreactive PGHS-2 in the decidua.  The 
amniontic PGE2 response observed when only the choriodecidual side was exposed to 
LPS could be due to passage of an inflammatory signal from the choriodecidua to initiate 
prostaglandin synthesis within the amnion.  However, absence of positive PGHS-2 
immunostaining in the amnion when only the choriodecidua was treated suggest that the 
PGE  originated in the choriodecidua.   2
The concentration-response experiments indicated a threshold effect on PGE2 
response to LPS stimulation.  No increase of PGE  concentrations was seen in the2  amnion 
or choriodecidua medium with LPS treatment concentrations ranging from 1 to 1000 
ng/ml.  Although not examined in this work, possible explanations for this threshold of 
response may be saturation of its co-receptors, CD-14 and toll-like receptor 4, or some 
other aspect of the signal transduction pathway.   
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Gestational membranes are sensitive to LPS concentrations as low as 1 ng/ml.  
Other researchers generally use between 100-1000 ng/ml LPS in cell and tissue culture 
experiments.  Of particular interest, Garcia-Lopez et al. (Garcia-Lopez, Vadillo-Ortega et 
al. 2007) observed degradation of the collagen in the mesenchymal layer of gestational 
membranes exposed to 500 ng/ml LPS for 24 h in Transwell cultures.  In the latter study, 
the effects on the compact collagen layer were proposed as a mechanism for preterm 
premature rupture of the membranes.  However, in the present study, gestational 
membranes treated with 100 ng/ml LPS treatment showed no evidence of compact layer 
degradation or other histopathology.  We conclude that there is little value in using 
excessively high LPS concentrations in gestational membrane experiments.  At least in 
the case of PGE2, a threshold response is reached at much lower LPS treatment 
concentrations without evidence of overt tissue damage or cytotoxicity.  
Lipopolysaccharide concentrations above 10 ng/ml are outside of the range of meaningful 
physiologic concentrations and may activate non-physiological pathways other than toll-
like receptor/CD-14 pathways (Levin, Pollack et al. 1998). 
Secretion of PGE2 into the amnion culture medium increased between 1 and 8 h 
of exposure to 100 ng/ml LPS, suggesting a steady rate of synthesis over that time period.  
The cellular and tissue responses to LPS occurred rapidly with increased PGE2 secretion 
after only 1 h of LPS exposure (Fig. 2A).  These results are in agreement with those of 
Brown et al. (Brown, Alvi et al. 1998), who observed a similar time-course with increases 
in PGE2 concentrations from floating intact gestational membrane cultures exposed to 
LPS for 1-8 h, and no further increase of PGE2 concentrations after 8 h.  Rajasingam et 
al. also reported significant increases in amniotic PGE2 production after 6 h of LPS 
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treatment in a dual-chambered culture system (Rajasingam, Bennett et al. 1998).  
However, they reported significant increases in choriodecidual PGE2 after 30 min of 
treatment (Rajasingam, Bennett et al. 1998), whereas our experiments failed to 
demonstrate significant increases of choriodecidual PGE2 release after 1, 4 or 8 h of LPS 
exposure (Fig. 2B).  The report by Rajasingam et al. suggested that the rapid PGE2 
increase observed in that study was due to activation of phospholipase A2, whereas 
responses requiring longer exposure durations could be due to increases in prostaglandin 
synthesis enzymes levels (Rajasingam, Bennett et al. 1998).  However, the latter 
explanation does not account for their observed differences between PGE  and PGF2 2α 
release. The activity of upstream enzymes, such as phospholipase A2, would presumably 
affect PGE  and PGF  synthesis equally.   2 2α
The leveling off of PGE2 accumulation seen in the choriodecidual medium of the 
Transwell system after 1 h of exposure may be due to a number of factors.  The shortened 
LPS-stimulated response observed in choriodecidua could be explained by a shorter 
duration of prostaglandin synthetic enzyme activation or by prostaglandin reuptake and 
catabolism.  Additionally, PGDH in the chorion trophoblast cells may metabolize 
prostaglandins in the choriodecidual tissue, thereby preventing additive accumulation of 
choriodecidual PGE2 during the 4 and 8 h treatments.  Alternatively, results presented in 
chapter 4 show that LPS exposure caused choriodecidual side-specific increase in IL-10, 
an anti-inflammatory cytokine.  Attenuation of the LPS inflammatory response by a 
compensatory anti-inflammatory cytokines could explain the patterns of time-dependent 
choriodecidual PGE  release observed in this study.   2
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Much effort has been focused on determining the ability of amniotic PGE2 to 
traverse the gestational membranes and reach the myometrium (Challis, Patel et al. 
1999).  Chorion trophoblast cells are thought to have high PGDH activity and, as such, to 
be able to rapidly catabolize prostaglandins.  In one popular model, chorionic PGDH is 
proposed to serve as an effective metabolic barrier to the passage of prostaglandins from 
the amnion to the decidua and myometrium (Challis, Patel et al. 1999).  The presence of 
PGDH in gestational membrane tissues could explain the lack of choriodecidual 
prostaglandin release when only the amnion side was stimulated, as well as the absence 
of prostaglandins in choriodecidual medium at the 24 h time point.  Aside from this 
possibility, the results presented here indicate that LPS caused release of PGE2 and 
PGF2α from the choriodecidua regardless of amniotic involvement.  Therefore, 
discussions about whether amniotic epithelium prostaglandins cross the gestational 
membranes to reach the myometrium may have limited relevance to the in vivo situation.  
However, the contrary case whereby choriodecidual inflammatory exposure causes 
amniotic prostaglandin release without evidence of mesenchymal PGHS-2 induction 
suggests passage of prostaglandins from the choriodecidua to the amnion.  This scenario 
may have clinical relevance because intra-amniotic prostaglandin release from 
choriodecidual response to ascending infection may harm the fetus. 
In recent years the existence of prostaglandin transporters has become known 
(Kanai, Lu et al. 1995), but no prostaglandin transporters have been identified in human 
gestational membranes to date.  Prostaglandin transporters facilitate passage of 
prostaglandins into cells in conjunction with lactate exchange (Chan, Endo et al. 2002).  
Characterization of prostaglandin transporters in gestational membranes may further 
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explain the source and signaling dynamics of prostaglandins in gestational membranes 
and myometrium. 
In vivo, the presence of bacteria, LPS and other bacterial products may augment 
the inflammatory response and change the dynamics of prostaglandin secretion in the 
membranes.  Therefore, lipopolysaccharide alone may not fully elicit effects on 
membrane integrity or passage of the inflammatory signal from one side of the 
membranes to the other.  Presumably, the inflammatory response would be prolonged and 
augmented by mobilization of inflammatory cells to the gestational membranes.  
However, in the ex vivo experimental model utilized here, the membranes are isolated 
from such body-wide immunological responses. 
  In conclusion, the present study demonstrated that LPS caused secretion of 
uterotonic prostaglandins from both the amnion and choriodecidual sides of intact, non-
laboring human gestational membranes in vitro.  Immunohistochemistry revealed a 
regional induction of PGHS-2 that correlated with secreted prostaglandins in side-specific 
exposure experiments.  Lipopolysaccharide stimulation of uterotonic prostaglandins from 
the choriodecidua of non-laboring gestational membranes may demonstrate a 
pathological induction of PGHS-2 and prostaglandin synthesis that could explain some 
mechanisms of preterm parturition.  However, it remains possible that gestational 
membranes may respond differently at earlier gestational ages compared with the term 











































Figure 3.1.  Concentration-dependent stimulation of PGE2 release from amnion or 
choriodecidual side of human full-thickness gestational membranes in Transwell 
tissue culture following an 8-h LPS exposure.   The x-axis shows the side of the 
gestational membranes assayed.  The legend indicates the side of the gestational 
membranes exposed to LPS or not-treated (NT; controls).  Values are expressed as mean 
± SEM (n= 6 specimens) *Significantly different from choriodecidua non-treated control 
(NT; p < 0.05). 
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Figure 3.2.  Time-dependent simulation of PGE2 release from full-thickness human 
t from 
gestational membranes in Transwell cultures of non-treated controls (NT) or 
following exposure to 100 ng/ml LPS .  A) PGE2 concentrations in amnion chamber 
medium.  B) PGE2 concentrations in choriodecidua chamber medium.  Values are 
expressed as mean ± SEM (1 h n= 6, 4 h n=8, 8 h n=11, 24 h n=4).  #Significantly 
different from time points indicated within treatment group. *Significantly differen














































































































































































Figure 3.3.  Side-specific stimulation of PGE  and PGF2 2α release from human full-
thickness gestational membranes following an 8-h side-specific LPS exposure (100 
ng/ml).  A) PGE  concentrations in culture medium.  B) PGF2 2α concentrations in culture 
medium.  The x-axis shows the side of the gestational membranes assayed.  The legend 
indicates the side of the gestational membranes exposed to LPS or not-treated (NT; 
controls).  Values are expressed as mean ± SEM (n=6). #Significantly different from 
treatments or controls indicated.  *Significantly different from amnion of the same 
treatment (p< 0.05). 
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Figure 3.4.  Prostaglandin endoperoxide H synthase-2 (PGHS-2) immunostaining in 
gestational membrane sections following side-specific LPS exposure.  There is no 
evidence of PGHS-2 in non-treated control samples (A, B).   In tissues treated with LPS 
on the amnion side only, amnion & chorion mesenchymal cells stain positive (brown) for 
PGHS-2 (C), but not decidual cells (D).  In tissues treated with LPS on the 
choriodecidual side only, decidual cells stain positive for PGHS-2 (F), but not amnion or 
chorion cells (E).  In tissues treated with LPS on both sides of the membrane, positive 
PGHS-2 staining is seen in amnion and chorion mesenchymal cells (G) and decidual cells 
(H). Arrows indicate IL-6 staining (brown).
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The objective of this study is to utilize lipopolysaccharide (LPS) as a model 
inflammatory agent to study the side-specific dynamics of cytokine responses in non-
laboring gestational membranes.  Non-labored gestational membranes were collected 
from healthy women undergoing elective Cesarean section deliveries at 37-39 weeks 
gestation.  Intact gestational membranes comprised of amnion, chorion and decidua were 
cultured on Transwell frames to create distinct chambers for measuring cytokines 
secreted into the amnion and choriodecidual culture media.  Concentration dependent 
release of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-4 (IL-4), 
interluekin-6 (IL-6), interluekin-8 (IL-8), interleukin-10 (IL-10) and transforming growth 
factor-β (TGF-β) were measured in Transwell culture medium after an 8-h exposure to 
LPS on both sides, over concentrations from 1-1000 ng/ml LPS. Side-specific cytokine 
responses were measured following stimulation with 100 ng/ml LPS on the amnion side 
only, the choriodecidual side only or both sides of the membranes.  Distinct patterns of 
response were seen for individual cytokines.  In particular, TNF-α, IL-1β and IL-6 
concentrations were significantly increased on both the amnion and choriodecidual side 
of the membranes after an 8-h LPS exposure.  In contrast, IL-8 and IL-10 were increased 
only on the choriodecidual side of the membranes.  LPS stimulation did not affect 
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gestational membrane secretion of IL-4 or TGF-β.  The results provide evidence for 
inflammatory signaling across the gestational membranes. The ex vivo side-specific 
cytokine responses to LPS seen here are consistent with the tissue specificity of cytokine 
production reported in vivo under term and preterm laboring conditions.   
INTRODUCTION 
Although cytokines have traditionally been thought to be immune cell 
messengers, understanding of their functions has expanded in recent years.  Cytokines 
have roles in placental hormone production, prostaglandin production, cervical ripening 
and membrane remodeling and rupture (Bowen, Chamley et al. 2002).  Interleukin-6, IL-
8 and TNF-α are detected in cervico-vaginal fluids in the third trimester of pregnancy 
before the onset of labor and increase after the onset of labor.  In amniotic fluid, IL-1β, 
IL-6, IL-8 and TNF-α concentrations are elevated after the onset of labor.  Additionally, 
IL-1β, IL-6, IL-8 and TNF-α expression are increased in cells or tissues from gestational 
membranes after the onset of labor, although reports are inconsistent (reviewed in 
(Bowen, Chamley et al. 2002). 
Because cytokine patterns are similar in preterm and term birth, it has been 
suggested that pathologic activation of the inflammatory pathway may be a mechanism of 
preterm birth due to preterm premature rupture of the membranes or spontaneous preterm 
contractions.  The objective of the present study was to use LPS as a model inflammatory 
agent to study the side-specific dynamics of TNF-α, IL-1β, Il-4, IL-6, IL-8, IL-10 and 
TGF-β responses in non-laboring gestational membranes.   
 73
MATERIALS AND METHODS 
Chemicals, Reagents and Antibodies 
Tissue culture reagents including high glucose Dulbecco’s Modified Eagle’s 
Medium (DMEM) with no phenol red, penicillin/streptomycin antibiotic, and heat-
inactivated fetal bovine serum were purchased from Invitrogen (Carlsbad, CA).  
Lipopolysaccharide (LPS) from Salmonella Typhinurium (Lot #225) was purchased from 
List Biological Laboratory (Campbell, CA).  Transwell frames with no micropore 
membrane insert were a gift from Corning Corporation (Corning, NY).   
Tissue Collection 
Methods pertaining to human tissue were reviewed and approved by the local 
Institutional Review Board (IRB) prior to initiation of experiments; review and approval 
were updated yearly.  Full-thickness gestational membranes comprised of amnion, 
chorion and decidua were collected at 37-39 weeks from non-laboring elective Cesarean 
sections following healthy pregnancies. Exclusion criteria included smoking, multi-fetal 
gestation, complications of pregnancy such as gestational diabetes or hypertension, use of 
anti-inflammatory drugs, or any other condition which would require the tissue to be sent 
to pathology.  Within 1-30 min after delivery, full-thickness extraplacental membranes 
were sharp dissected from the placenta, placed in phosphate buffered saline solution and 
transported to the laboratory.   
Tissue Culture 
In the laboratory, membranes were checked for integrity under sterile conditions 
to ensure that the amnion and choriodecidua remained attached to one another and that 
the collagen compact layer between the amnion and the choriodecidua was not degraded.  
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The membranes were rinsed with culture medium (DMEM supplemented with 1% heat 
inactivated-fetal bovine serum and 100 units penicillan/100 μg streptomycin per 
milliliter) to remove excess blood clots.  The membranes were cut into approximately 2 x 
2 cm2 pieces and affixed by latex bands onto ethylene oxide sterilized Transwell frames 
(without a micropore membrane) to create two distinct chambers on either side of the 
mounted membranes (Zaga, Estrada-Gutierrez et al. 2004).  The choriodecidual side of 
the tissue faced the inner chamber of the device.  Extra tissue was removed with a 
scalpel.  Each Transwell frame with attached tissue was placed in a single well of a 12-
well plate with culture medium on both sides of the membranes.  Mounted membranes 
were equilibrated in a 5% CO2 tissue culture incubator.  To maintain optimal culture 
conditions and health of the tissue, membranes in culture media were equilibrated for 18-
24 h with a medium change after the first 2-4 h.  Prior to beginning the treatment 
protocol, the overnight culture medium was removed and the membranes were pretreated 
with fresh culture medium for 1-2 h.  
Treatment 
Lipopolysaccharide was diluted in sterile, deionized water to make a primary 
stock of 100 µg/ml.  Just prior to the experiment, the LPS primary stock was further 
diluted with culture medium (DMEM plus 1% FBS and antibiotics) to achieve the desired 
experimental concentration (1-1000 ng/ml, as indicated), and added to one or both 
chambers of the Transwell culture. In cases where only one side of the membranes was 
treated with LPS, the opposite side was cultured in culture medium.  Mounted intact 
gestational membrane pieces were assigned randomly to treatment groups with three 
pieces of tissue included in each treatment.  After the 8-h treatment, the medium was 
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recovered from each side of the membranes and stored at -20°C or -80°C for subsequent 
enzyme immunoassay analysis of cytokines.  After collection of medium, the tissue was 
removed from the Transwell device and weighed. 
Cytokine Enzyme-linked Immunosorbant Assays (ELISA)  
Cytokine sandwich ELISAs for TNF-α, IL-1β, IL-4, IL-6, IL-8, IL-10, and TGF-
β were conducted by the University of Michigan Cellular Immunology Core Facility.  
DuoSet ELISA Development Systems assay kits specific for each antigen were 
performed according to the manufacturer’s protocol (R & D Systems, Minneapolis, MN).  
The assay buffer used was 0.2% casein in tris-buffered saline. 
Cytokine concentrations (pg/ml) were divided by the wet weight of the intact 
gestational membrane tissue taken after the experiment and the mean of the treatment 
replicates per gram of tissue was calculated.  This overall mean for each specimen/subject 
was calculated and combined with results from other subjects.  Mean results and standard 
error of the mean were calculated from multiple subjects and graphed with n referring to 
the number of subjects in each experiment. 
Statistical Analyses 
Before analysis, cytokine concentrations below the limit of detection for the assay 
were given a value of 0.01 pg/ml.  The cytokine enzyme immunoassay results were 
analyzed by one-way or two-way analysis of variance (ANOVA) using SigmaStat v 3.5 
software (Systat Software, Inc., Richmond, CA).  Prior to analysis, the data were 
transformed using log normal transformation to correct for non-normality.  Post hoc pair-
wise comparisons of means were performed by the Student-Newman-Keuls methods.  A 
p-value < 0.05 was considered statistically significant.   
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RESULTS 
 Gestational membrane cytokine responses to LPS were assessed using membranes 
cultured on Transwell frames and exposed to 100 ng LPS/ml for 8 h.  Cytokines released 
by the amnion side or choriodecidua side of the gestational membranes were measured in 
the medium of each chamber of the Transwell culture.  For each cytokine, concentration-
response and side-specific exposure/response experiments were performed.    
TNF-α 
 TNF-α was not detected in the medium of control gestational membrane cultures, 
yet LPS strongly stimulated TNF-α release from both the amnion and choriodecidual 
sides of the membranes (Fig. 4.1).  The LPS-stimulated TNF-α levels were at least 
10,000-fold higher than those of the control cultures.   
TNF-α release was not concentration-dependent when LPS was added to both 
sides of the gestational membranes in Transwell cultures.  Instead, TNF-α release reached 
a plateau at low concentrations of LPS with no further significant increases at higher LPS 
concentrations (Fig. 4.1A).  Statistically significant levels of TNF-α were measured in 
the amnion-side culture medium at all concentrations of LPS treatment (1-1000 ng/ml) 
compared with controls (p < 0.05).  On the choriodecidual side, TNF-α concentrations 
from cultures treated with 10 or 100 ng/ml LPS were significantly different from controls 
(p < 0.05). 
Side-specific LPS exposures revealed dynamics of TNF-α response in the 
gestational membranes.  Regardless of whether LPS treatment was on the amnion side 
only, choriodecidual side only or both sides simultaneously, 100 ng/ml LPS stimulated 
significant release from both the amnion and the choriodecidua sides of the membranes 
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relative to controls (Fig. 4.1B; p<0.05). Nevertheless, the TNF-α response was higher on 
the LPS-treated side of the membranes.  Specifically, TNF-α concentrations were higher 
in medium from the amnion side of the culture after LPS treatment of the amnion side 
compared with LPS treatment of the choriodecidual side of the membranes (Fig. 4.1B, 
left side; p < 0.05).  Likewise, LPS treatment of the choriodecidua side of the membranes 
elicited a greater response from the choriodecidua side of the membranes compared with 
the amnion side of the membranes (Fig. 4.1B, right side; p<0.05).  In addition, more 
TNF-α was secreted into the amnion culture medium when only the amnion side was 
treated compared to when only the chorion side was treated (p<0.05).  The same pattern 
occurred for TNF-α concentrations in the medium from the choriodecidua side, with 
more TNF-α detected in the choriodecidua culture medium when only the choriodecidua 
side was treated compared to when only the amnion side was treated (p<0.05).  These 
side-specific exposure/response results indicate that TNF-α or a TNF-α releasing signal 
passed from one side of the membranes to the other.   
IL-1β 
 Gestational membranes released minimal IL-1β under control culture conditions 
and a modest amount of IL-1β in response to LPS stimulation (Fig. 4.2).  The IL-1β 
concentrations after treatment with LPS on both the amnion and choriodecidual sides of 
the membranes did not vary in a concentration-dependent manner (Fig. 4.2A). There was 
a significant increase of IL-1β in amnion-side medium with 10 ng/ml LPS treatment and 
a significant increase in IL-1β in choriodecidual-side medium with 10 and 100 ng/ml 
LPS treatment (Fig. 4.2A; p<0.05).  No statistically significant IL-1β responses were 
detected side-specific exposure to 100 ng/ml LPS (Fig. 4.2B). 
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IL-6 
 IL-6 release was not concentration-dependent when LPS was added to both sides 
of the gestational membranes in Transwell cultures.  The increased amounts of IL-6 
released into the medium were statistically significant compared with controls only for 
the choriodecidual side after treatment on both sides of the membranes with 10 ng/ml 
LPS (Fig. 4.3A; p < 0.05,).   
In the side-specific exposure experiments, 100 ng/ml LPS, stimulated increased 
IL-6 release from the amnion side of the membranes with LPS treatment to the amnion 
side only or to both the amnion and choriodecidua sides (p < 0.05, relative to controls), 
but not when LPS treatment was restricted to the choriodecidual side only (Fig. 4.3B, left 
side).  Measurements of the choriodecidual IL-6 response indicated that LPS stimulated 
significantly more IL-6 release than control conditions, regardless of whether the LPS 
was added to the amnion side only, choriodecidua side only, or both sides simultaneously 
(Fig. 4.3B, right side; p < 0.05).  Thus, LPS treatment of the amnion side only increased 
choriodecidual IL-6 response, whereas LPS treatment of the choriodecidual side only did 
not increase the IL-6 response on the amnion side of the membranes.   
IL-8 
 Both the amnion and choriodecidua sides of the gestational membranes released 
substantial amounts of IL-8 in the Transwell cultures under control conditions (Fig. 4.4).  
However, only the choriodecidua responded to LPS treatment with increased production 
of IL-8.  Exposure to 10 or 100 ng/ml LPS on both sides of the membranes significantly 
increased IL-8 production from the choriodecidual side compared to the same exposure 
concentrations on the amnion side (Fig. 4.4A; p < 0.05).  With side-specific exposures, 
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LPS treatment (100 ng/ml) on the choriodecidual side of the membranes or both sides of 
the membranes caused increased IL-8 release from the choriodecidual side of the 
membranes compared to the amnion side of the membranes exposed to the same LPS 
concentration (Fig. 4.4B; p < 0.05).   
IL-10 
 Treatment with 100 ng/ml LPS failed to stimulate significant release of IL-10 
from the amnion side of the membranes (Fig. 4.5).  In contrast, there was a significant 
increase in IL-10 release on the choriodecidual side compared to controls, regardless of 
whether the gestational membranes were treated with LPS on the amnion, choriodecidual 
or both sides of the membranes (p<0.05).  When both sides of the membranes were 
treated with LPS, the choriodecidual response was approximately 10-fold higher than 
control levels.  In addition, the IL-10 concentrations were significantly higher on the 
choriodecidual side compared to the amnion side for cultures treated with LPS on the 
choriodecidual side only or on both the amnion and choriodecidual sides (comparing 
right and left sides of Fig. 4.5; p<0.05).  These data indicate that the choriodecidua is the 
dominant producer of IL-10 in human gestational membranes in this system. 
TGF-β and IL-4 
 No statistically significant changes were observed for TGF-β or IL-4 release by 
the amnion or choriodecidual side of the membranes in response to treatment with 100 
ng/ml LPS (data not shown). 
DISCUSSION 
 In this study, gestational membranes were cultured on Transwell frames enabling 
measurement of side-specific cytokine secretion after LPS treatment.  Tumor necrosis 
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factor-α, IL-1β and IL-6 concentrations were significantly increased on both the amnion 
and choriodecidual sides of the membranes after an 8-h LPS exposure.  In contrast, IL-8 
and IL-10 were increased only on the choriodecidual side of the membranes.  LPS 
stimulation did not affect secretion of IL-4 or TGF-β. This is the first report of LPS-
stimulated side-specific release of IL-4 IL-6, IL-8, IL-10, and TGF-β from gestational 
membranes.  
TNF-α responded dramatically to LPS treatment.  Both amnion and 
choriodecidual sides of the membrane exhibited robust TNF-α responses to LPS 
treatment in the range of 10,000 to 20,000 times the control levels.  When LPS was 
applied to only one side of the membrane, a TNF-α response was seen on the opposite 
side.  Although the opposite-side responses were attenuated compared to same-side 
responses, these results indicated the passage of an inflammatory signal or the cytokine 
itself from one side of the membrane to the other.  In a similar experiment, Zaga et al. 
reported that the choriodecidual TNF-α response predominated over the amnion response 
when membranes were treated in a side-specific manner with 500 ng/ml LPS for 24 h, 
though no statistics substantiated this claim (Zaga, Estrada-Gutierrez et al. 2004).  
Research by the same group reported a TNF-α response to side-specific Escherichia coli 
infection only when both sides of the membranes were treated (Zaga-Clavellina, Garcia-
Lopez et al. 2007).   
Increases in TNF-α in the amniotic fluid are associated with the onset of labor at 
term (Bowen, Chamley et al. 2002) and before 37 weeks gestation (Figueroa, Garry et al. 
2005) .   Evidence exists for TNF-α as a causal mediator of term and preterm birth.  It is 
known to stimulate prostaglandin F2α production from isolated term decidua cells 
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(Norwitz, Lopez Bernal et al. 1992).  Intra-amniotic injection of TNF-α into pregnant 
rhesus monkeys caused onset of preterm uterine contractions, as well as elevations of 
other amniotic fluid cytokines, prostaglandins and matrix metalloproteinase 9 (Sadowsky, 
Adams et al. 2006).   
 In the present experiment, the IL-1β response was modest with low overall 
concentrations measured in response to LPS treatments.  Because of the low 
concentrations in the sample, we were not able to obtain statistical significance with our 
sample size (n = 5 subjects) in the side-specific experiments.  In contrast, Zaga et al. 
(Zaga, Estrada-Gutierrez et al. 2004) saw a robust IL-1β response on both the amnion and 
choriodecidua sides of the membranes when tissues were treated with 500 ng/ml LPS for 
24 h.  Differences between our results and those of Zaga et al. (Zaga, Estrada-Gutierrez et 
al. 2004) may be due to different LPS concentrations or lengths of exposure used in the 
studies. When membranes in Transwell culture were infected with E. coli for 24 h, the 
primary response was from the choriodecidual side (Zaga-Clavellina, Garcia-Lopez et al. 
2007).   
 Concentrations of IL-1β measured in the Transwell culture system may be low 
due to inability of leukocytes to accumulate in gestational tissues in response to 
inflammatory stimulus.  Evidence exists that IL-1β is a potent activator of uterine 
contraction, because intra-amniotic infusions of pregnant rhesus monkeys causes 
powerful preterm contractions (Sadowsky, Adams et al. 2006). 
 High levels of IL-6 were secreted from both sides of the gestational membranes 
under LPS-stimulated or control conditions. Lipopolysaccharide-stimulated IL-6 
concentrations were approximately 4-fold higher than non-stimulated levels.  In side-
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specific exposure experiments, increased IL-6 was always detected on the side of the 
membrane exposed to the stimulus.  In addition, some IL-6 was measured on the 
choriodecidual side of the membrane when only the amnion side was treated.  The latter 
finding suggests that transfer of IL-6 or an inflammatory mediator occurs from the 
amnion to the choriodecidua.  Similar IL-6 secretion patterns are seen in response to side-
specific E. coli exposure (Zaga-Clavellina, Garcia-Lopez et al. 2007).  Production of IL-6 
under basal conditions reported here conflicts with a previous report by Dudley et al. 
(1996) that showed little IL-6 mRNA is detected in non-laboring membranes (Dudley, 
Collmer et al. 1996).  Secretion of IL-6 in ex vivo culture may be a result of an 
inflammatory reaction to tissue preparation procedures or culture conditions.   
High levels of IL-6 are measured in the amniotic fluid during term and preterm 
parturition, and are associated with neonatal morbidities such as bronchopulmonary 
dysplasia and cerebral palsy (Hagberg, Mallard et al. 2005).  However, IL-6 may be a 
marker of inflammation rather than a causal agent for preterm birth, because intra-
amniotic infusions into pregnant rhesus monkeys fail to elicit preterm labor or birth 
(Sadowsky, Adams et al. 2006). 
The IL-8 response was striking in that LPS stimulated no excess IL-8 from the 
amnion side of the membranes.  The side-specific nature of the IL-8 response may 
indicate a role in fighting off ascending infection. Though amnion makes IL-8 under 
basal conditions, no additional IL-8 was released by the amnion in response to LPS 
stimulation.  Intra-amniotic infusion of IL-8 to pregnant rhesus monkeys does not cause 
preterm labor (Sadowsky, Adams et al. 2006).  It is possible that IL-8 response and 
effects are significant only on the choriodecidual side of the membrane. 
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Similar to IL-6, basal secretion of IL-8 was high on both sides of the membranes. 
LPS-stimulated concentrations were at most 2-fold higher than control concentrations on 
the choriodecidual side of the membranes only.  The absence of LPS-stimulated IL-8 
release on the amniotic side of the membranes is in contrast to earlier reports showing 
LPS increases IL-8 secretion from isolated amnion cells as well as from decidual cells 
(Makhlouf and Simhan 2006).  Transwell cultures treated with E. coli had lower basal 
secretions of IL-8 compared to our system, with responses to treatment seen on both sides 
of the membranes (Zaga-Clavellina, Garcia-Lopez et al. 2007).    
The choriodecidua exhibited a marked IL-10 response to LPS exposures.  When 
both sides were treated with LPS, IL-10 concentrations were approximately 10-fold 
higher than control levels.  Like IL-8, there was no IL-10 response to LPS stimulation on 
the amnion side of the membranes.  However, there was very little amnion-side secretion 
of IL-10 in general, suggesting that the amnion side may have limited capacity for 
producing and/or secreting IL-10. 
The anti-inflammatory properties of IL-10 could limit the inflammatory cytokine 
responses seen here and the prostaglandin responses reported in Chapter 3.  IL-10 null 
mutant mice were more susceptible to LPS-induced fetal loss (a model for preterm 
delivery) than wild-type mice.  Exogenous IL-10 protected both IL-10 knockout mice and 
wild-type mice from fetal loss, suggesting that up-regulation of IL-10 and subsequent 
anti-inflammatory effects are important for preventing preterm labor due to inflammatory 
stimuli (Robertson, Skinner et al. 2006).   
 The side-specific cytokine responses seen with ex vivo tissue exposure to LPS are 
consistent with tissue specificity of cytokine production observed in gestational 
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membranes from term and preterm labor.  We detected LPS-stimulated increase of TNF-
α, IL-1β and IL-6 in medium from both sides of the membrane culture. These results 
correspond with detection of TNF-α, IL-1β and IL-6 in amniotic fluid from cases of 
preterm and term labor (Bowen, Chamley et al. 2002).  Similarities seen here may be due 
to inherent abilities in the amnion to initiate an inflammatory response.  Likewise, IL-1β, 
IL-6 and IL-8 are detected in cervico-vaginal fluids in cases of spontaneous term 
parturition and preterm labor (Bowen, Chamley et al. 2002).  We measured these 
cytokines in medium from the choriodecidual sides of the membrane (in addition to TNF-
α and IL-10), indicating that the LPS-stimulated choriodecidual response of the ex vivo 
gestational membranes is similar to in vivo laboring conditions.   
   Inflammatory cytokine responses are elevated in preterm birth cases associated 
with infection.  In vivo, intrauterine infection is characterized by influx of immune cells 
to the uterus.  Therefore, the origin of cytokines in amniotic fluid or gestational tissues in 
cases of preterm birth may be due to expression from mobilized immune cells.  Here we 
see cytokine responses from tissues cultured ex vivo that are isolated from a systemic 
immune response, suggesting that membranes themselves, rather than infiltrating immune 
cells, are a source of inflammatory cytokines.    
In summary, utilization of the Transwell tissue culture system allowed 
characterization of distinct patterns of cytokine release from human gestational 
membranes.  Although IL-1β, IL-6, IL-8 and TNF-α are acute phase cytokines, each 
responds differently to LPS stimulation.  Interleukin-6 and IL-8 have high basal levels of 
secretion from non-laboring term gestational membranes and modest response to LPS 
stimulation, though no additional IL-8 is made on the amnion side.  Interleukin-1β and 
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TNF-α had low levels of basal secretion, but only TNF-α responded significantly to 
stimulus.  Although IL-4, IL-10 and TGF-β are anti-inflammatory cytokines that are 
important for controlling response to stimulus, only IL-10 was made in response to LPS.  
Together, these results point to a complicated network of intra-gestational membrane 
signaling and response to an inflammatory stimulus.  More work is needed to clarify the 
causal or associative roles each cytokine plays in the inflammatory response in these 




































































































Figure 4.1.  Side-specific LPS-stimulated release of TNF-α from intact human 
gestational membranes in Transwell cultures.  TNF-α concentrations were measured 
in medium from the amnion or choriodecidual side of the Transwell cultures.  A) 
Concentration-response of TNF-α release after an 8-h exposure to 1, 10, 100 or 1000 
ng/ml LPS (n = 7 subjectss). B) TNF-α release after an 8-h exposure to 100 ng/ml LPS  
on the amnion side only (A), choriodecidua side only (CD) or both sides of the 
membranes (A-CD)  (n = 5 subjects). Controls (cont) were exposed to culture medium 
only.  The very low means of controls are nearly contiguous with the x-axis.  Values are 
expressed as mean ± SEM.  ‡Significantly different from controls (cont) within tissue (p 
< 0.05). #Significantly different from designated treatment groups within tissue (p < 







































































Figure 4.2.  Side-specific LPS-stimulated release of IL-1β from intact human 
gestational membranes in Transwell cultures.  Medium from the amnion or 
choriodecidual side of the Transwell cultures was sampled and IL-1β concentrations were 
analyzed by ELISA.  A) Concentration-response of IL-1β release from membranes 
exposed for 8 h to 1, 10, 100, or 1000 ng/ml LPS (n = 7 subjects). B) IL-1β release from 
membranes exposed to LPS (100 ng/ml) on the amnion side only (A), choriodecidua side 
only (CD) or both sides of the membranes (A-CD) for 8 h (n = 5 subjects). Control 
cultures (cont) were exposed to culture medium only.  Values are expressed as mean ± 










































































Figure 4.3.  Side-specific LPS-stimulated release of IL-6 from intact human 
gestational membranes in Transwell cultures.  Medium from the amnion or 
choriodecidual side of the Transwell cultures was sampled and IL-6 concentrations were 
analyzed by ELISA.  A) Concentration-response of IL-6 release from membranes 
exposed for 8 h to 1, 10, 100, or 1000 ng/ml LPS (n = 7 subjects). B) IL-6 release from 
membranes exposed to LPS (100 ng/ml) on the amnion side only (A), choriodecidua side 
only (CD) or both sides of the membranes (A-CD) for 8 h (n = 5 subjects). Control 
cultures (cont) were exposed to culture medium only.  Values are expressed as mean ± 
SEM.  ‡Significantly different from control (cont) within tissue (p < 0.05). #Significantly 

























































Figure 4.4.   Side-specific LPS-stimulated release of IL-8 from intact human 
gestational membranes in Transwell cultures.  Medium from the amnion or 
choriodecidual side of the Transwell cultures was sampled and IL-8 concentrations were 
analyzed by ELISA.  A) Concentration-response of IL-8 release from membranes 
exposed for 8 h to 1, 10, 100, or 1000 ng/ml LPS (n = 7 subjects). B) IL-8 release from 
membranes exposed to LPS (100 ng/ml) on the amnion side only (A), choriodecidua side 
only (CD) or both sides of the membranes (A-CD) for 8 h (n = 5 subjects). Control 
cultures (cont) were exposed to culture medium only.  Values are expressed as mean ± 


































Figure 4.5.  Side-specific LPS-stimulated release of IL-10 from intact human 
gestational membranes in Transwell cultures.  Medium from the amnion or 
choriodecidual side of the Transwell cultures was sampled and IL-10 concentrations were 
analyzed by ELISA.  IL-10 release was measured from membranes exposed for 8 h to 
LPS (100 ng/ml) on the amnion side only (A), choriodecidua side only (CD) or both sides 
of the membranes (A-CD) (n = 5 subjects). Control cultures (cont) were exposed to 
culture medium only.  Values are expressed as mean ± SEM.  ‡Significantly different 
from control (cont) within tissue (p < 0.05). #Significantly different from designated 
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PROSTAGLANDIN SYNTHESIS AND CATABOLISM IN GESTATIONAL 
TISSUES IS NOT AFFECTED BY PCB 153 STIMULATION 
 
ABSTRACT 
Previous research has established that the environmental toxicants, 
polychlorinated biphenyls (PCBs) are present within the uterus during pregnancy.  
2,4,5,2’,4’,5-hexachlorinated biphenyl (PCB 153) is a predominate congener found in the 
environment and induces prostaglandin endoperoxide H synthase-2 (PGHS-2), a rate-
limiting enzyme in prostaglandin synthesis, and interleukin-6, (IL-6) an inflammatory 
cytokine.  Increased prostaglandin and cytokine expression in gestational membranes are 
associated with the onset of term and preterm parturition.  The immediacy of PCBs to 
sites of utero-placental prostaglandin synthesis, metabolism and action creates the 
potential for toxicant disruption of the concentration, distribution and activity of 
prostaglandins and other inflammatory mediators with implications for the disruption of 
parturition.  Placentas and intact gestational membranes comprised of fused amnion, 
chorion and decidua were collected at 37-39 weeks from non-laboring elective Cesarean 
sections following healthy pregnancies.  Placental cells were cultured from the villous 
placenta and intact gestational membrane tissues were cultured on Transwell frames.  The 
effects of PCB 153 on prostaglandin synthesis in gestational membranes were evaluated 
because preliminary experiments in villous placental trophoblast cells indicated that PCB 
153 inhibited the conversion of exogenous PGF2α to a metabolite, suggesting an effect on 
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15-hydroxy prostaglandin dehydrogenase (PGDH) activity.  However, after 1, 4 or 8 h of 
PCB treatment no effect on PGE2, PGF2α or IL-6 secretion from either side of gestational 
membranes was detected.  To determine whether PCB 153 caused sensitization to 
lipopolysaccharide (LPS)-induced inflammation, gestational membranes from one subject 
were exposed to PCB 153 for 18 h followed by LPS and PCB 153 for 8 h.   However, no 
significant increase in prostaglandin release was seen under these exposure conditions 
compared to controls.  Experiments described here indicate the absence of an effect of 
PCB 153 on gestational membrane prostaglandin production. 
INTRODUCTION 
Polychlorinated biphenyls (PCBs), are persistent organic toxicants that are 
ubiquitously present in the soil, groundwater and sediment, and consequently 
bioaccumulate in the food chain (Patandin, Koopman-Esseboom et al. 1998).  Body 
burdens above typical background levels are due to occupational exposures or 
consumption of specific food products such as Great Lakes sport fish (Stewart, Darvill et 
al. 1999).  In humans these toxicants have long half-lives (~10 years) because they are 
poorly metabolized and lipophilic (Jacobson, Fein et al. 1984).  
Previous research has established that PCBs are present in the placenta and uterus 
during pregnancy.  In one study, the extracted lipids of the uterine muscle, placenta and 
amniotic fluid had relatively high levels of PCBs compared to maternal serum, with the 
highest levels being in the lipids of the amniotic fluid (Polishuk, Wassermann et al. 
1977).  A more contemporary study of women exposed to background levels of 
environmental pollutants found one in three amniotic fluid samples contained detectable 
levels PCBs (Foster, Chan et al. 2000).  The immediacy of these toxicants to sites of 
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uteroplacental prostaglandin synthesis, metabolism and action creates the potential for 
toxicant disruption of the concentration, distribution and activity of prostaglandins. 
Known actions of PCBs suggest plausible potential mechanisms for disruption of 
prostaglandins during pregnancy.  2,4,5,2’,4’,5-Hexachlorinated biphenyl (PCB 153) 
(Fig. 5.1) is a predominate coplanar congener found in the environment (Dabrowska, 
Fisher et al. 2006).  A coplanar PCB mixture that includes PCB 153 induces expression 
of prostaglandin endoperoxide H synthase-2 (PGHS-2) mRNA and reduces expression of 
interleukin-1β (IL-1β) mRNA in rabbit pre-implantation embryos (Kietz and Fischer 
2003).  In human mast cells, PCB 153 induces PGHS-2 and interleukin-6 mRNA by a 
nuclear factor-κB (NF-κB)-dependent mechanism (Kwon, Lee et al. 2002).  Because 
PGHS-2, IL-1β, IL-6 and NF-κB are important mediators of prostaglandin production in 
human gestational membranes (Lindstrom and Bennett 2005), their modulation by PCBs 
suggests a mechanism for toxicant disruption of prostaglandin metabolism and 
catabolism that may be relevant to parturition.   
Human gestational membranes are available from healthy, term human 
pregnancies.  Non-labored membranes from cesarean deliveries were obtained and 
cultured in a Transwell tissue culture as described in Chapter 2.  The objective of the 
present work was to determine whether PCB 153 affected PGDH activity in gestational 
tissues and to characterize gestational membrane prostaglandin secretion in response to 
PCB 153.  
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MATERIALS AND METHODS 
Chemicals, Reagents and Antibodies 
Tissue culture reagents including high glucose Dulbecco’s Modified Eagle’s 
Medium (DMEM) without phenol red, penicillin/streptomycin antibiotic, and heat-
inactivated fetal bovine serum were purchased from Invitrogen (Carlsbad, CA).  
Lipopolysaccharide (LPS) from Salmonella Typhinurium (Lot #225) was purchased from 
List Biological Laboratory (Campbell, CA) and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 
153) was purchased from AccuStandard, Inc. (New Haven, CT).  Prostaglandin E2 and 
PGF2α enzyme immunoassay kits were purchased from Cayman Chemical Co. (Ann 
Arbor, MI). Transwell frames with no micropore membrane insert were a gift from 
Corning Corporation (Corning, NY).   
Tissue Acquisition 
Methods pertaining to human tissue were reviewed and approved by the local 
Institutional Review Board prior to initiation of experiments; review and approval were 
updated yearly.  Intact gestational membranes comprised of fused amnion, chorion and 
decidua were collected at 37-39 weeks from non-laboring elective Cesarean sections 
following healthy pregnancies. Exclusion criteria included smoking, multi-fetal gestation, 
complications of pregnancy such as gestational diabetes or hypertension, use of anti-
inflammatory drugs, or any other condition which would require the tissue to be sent to 
pathology.  Within 1-60 min after delivery, full-thickness extraplacental membranes were 
sharp dissected from the placenta, placed in phosphate buffered saline solution and 
transported to the laboratory.  Alternatively, the entire placenta and attached membranes 
were transported to the laboratory. 
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Tissue Culture 
In the laboratory, under sterile conditions, membranes were checked for integrity 
to ensure that amnion and choriodecidua remained attached to one another and that the 
collagen compact layer between the amnion and the choriodecidua was not degraded.  
The membranes were rinsed with culture medium (DMEM supplemented with 1% heat 
inactivated-fetal bovine serum and 100 units penicillan/100 μg streptomycin per 
milliliter) to remove excess blood clots.  The membranes were cut into approximately 2 x 
2 cm2 pieces and affixed by latex rubber bands onto ethylene oxide sterilized Transwell 
frames (without a micropore membrane) to create two distinct chambers on either side of 
the mounted membranes (Zaga, Estrada-Gutierrez et al. 2004).  The choriodecidual side 
of the tissue faced the inner chamber of the device.  Extra tissue was removed with a 
scalpel.  Transwell frames with attached tissue were placed in 12-well plates with culture 
medium on both sides of the membranes.  Mounted membranes were cultured in a 5% 
CO2 tissue culture incubator.  To maintain optimal culture conditions and health of the 
tissue, the medium was changed after the first equilibration period of 2-4 h and then 
tissues were left overnight.  Prior to beginning the treatment protocol, the overnight 
culture medium was removed and the membranes were pretreated with fresh culture 
medium for 1-2 h.    
Placental and Chorionic Cell Isolation and Cell Culture 
Placental cells were cultured from the villous placenta and chorion.  Briefly, fresh 
placentas were collected from the University of Michigan hospitals following non-
laboring cesarean sections.  Villous placenta and chorion were dissected and subjected to 
digestion at 37°C by a trypsin/DNase or trypsin/DNase/collagenase solution, 
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respectively.  The digestion solution was strained through a 200 μm nylon membrane and 
placental cells were recovered by centrifugation.  Cells were purified on a 5-70% 
continuous Percoll gradient, washed, and plated on 96-well plates, 24-well plates (1 
million cells per well) or in 10 cm2 dishes (10 million cells) in media (DMEM) 
supplemented with 10% fetal bovine serum and 100 units penicillin-100 μg 
streptomycin/ml. Cells were washed, and medium was replenished on day one of culture.  
Experiments were conducted on day three of culture. 
Treatment 
The PCB 153 was dissolved in dimethyl sulfoxide (DMSO) to achieve a primary 
stock concentration of 10 mM.  The PCB 153 stock solution was diluted with culture 
medium at the time of the experiment to achieve the experimental concentration (10 µM).  
The positive control, LPS, was diluted in sterile, deionized water to make a primary stock 
of 100 µg/ml.  Just prior to the experiment, the LPS primary stock was further diluted 
with culture medium to achieve the experimental concentration (100 ng/ml).  To initiate 
exposure, medium was removed and fresh medium with PCB, LPS (positive control) or 
DMSO (solvent control) was added to both amnion and choriodecidual chambers of the 
culture dish. Mounted intact gestational membrane pieces were assigned randomly to 
treatment groups with three pieces of tissue included in each treatment.   Membranes 
were incubated with the treatments for 1, 4, 8 or 24 h.  After the specified treatment time, 
treatment medium was recovered from each side of the membrane and stored at -20°C or 
-80°C for subsequent enzyme immunoassay analysis of secreted PGE2 and PGF2α.  The 
tissue was removed from the frame and weighed.   
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Enzyme Immunoassay 
Prostaglandin E2 and PGF2α in the culture medium were assayed by enzyme 
immunoassay according to the manufacturer’s protocol (Cayman Chemical Co., Ann 
Arbor, MI).  Prior to the assay, samples were thawed and diluted to concentrations that 
fell within the range of the standard curve.  Each sample was assayed in duplicate.  
Prostaglandin concentrations were calculated using the analysis spreadsheet provided by 
the manufacturer.  Mean prostaglandin concentrations were divided by the wet weight of 
gestational membrane tissue pieces and the mean of the treatment replicates was 
calculated.  Mean results and standard error of the mean were calculated from multiple 
specimens and graphed.  
Statistical Analyses 
The prostaglandin enzyme immunoassay results were analyzed by one-way or 
two-way analysis of variance (ANOVA) using Sigma Stat v 3.5 software (Systat 
Software, Inc., Richmond, CA).  Prior to analysis, the data were transformed using log 
normal transformation to correct for non-normality.  Post hoc pair-wise comparisons of 
means were performed by the Student-Newman-Keuls methods.  A p-value < 0.05 was 
considered statistically significant. 
RESULTS 
Villous Trophoblast PGDH Activity Assay 
Trophoblast cells were cultured from placental villous tissue collected from 
healthy, term Cesarean section deliveries.  After isolation and equilibration in culture, 
cells were treated for 12 h with PCB 153, DMSO (solvent control) or TNF-α (positive 
control).  Additional unexposed cultures served as non-treated controls (NT).  Exposure 
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medium was removed from the cells and fresh medium containing exogenous PGF2α and 
indomethacin, a PGHS-2 inhibitor, was added.  To assess PGDH activity, PGF2α 
conversion media was recovered after 2 h and was analyzed for the presence of 13, 14-
dihydro-15 keto PGF2α metabolite (PGFM) by enzyme immunoassay.  PGFM was 
significantly decreased in cells treated for 12 hours with 50 µM PCB 153 or TNF-α 
compared to non-treated control and solvent control levels (Fig. 5.2).  Data presented 
here are from one cell isolation from one placenta.  Three wells of cells were exposed for 
each treatment or control condition.   
PCB 153 effects on PGE2 and PGF2α secretion 
 Because isolated cell experiments indicated an effect of PCB 153 on 
prostaglandin catabolism by PGDH, intact gestational membrane experiments were 
conducted to investigate a tissue response.  Intact gestational membrane pieces were 
mounted and cultured on Transwell devices allowing side-specific measurement of 
prostaglandins.  Membranes were treated with 10 µM of PCB 153 for 1, 4, or 8 h and 
PGE2 or PGF2a was measured in amnion and choriodecidual culture medium.   
 After 1, 4 or 8 h of PCB treatment, there was no effect of PCB 153 on PGE2 (Fig. 
5.3) or PGF2α secretion (Fig. 5.4) from either side of the gestational membranes.  Limited 
experiments with higher concentrations (25 µM or 50 µM) or longer exposure times (24 
h) showed no effect (data not shown).   
PCB 153/LPS co-exposure experiment 
 Although PCB 153 exposure showed no effect on prostaglandin secretion from 
gestational membranes, I hypothesized that PCB 153 might sensitize tissue to other 
inflammatory stimuli.  To investigate this hypothesis gestational membrane tissue was 
 100
treated with 25 or 50 uM PCB for 18 h followed by co-exposure with 25 or 50 uM PCB 
and10 or 100 pg/ml LPS stimulation for 8 h.  No significant effects were seen on PGE2 
secretion by the amnion or choriodecidual side of gestational membranes under these 
exposure conditions.   
DISCUSSION 
 Preliminary experiments indicated that PCB 153 inhibited the conversion of 
exogenous PGF2α to PGFM, suggesting an effect on PGDH in villous placental 
trophoblast cells.  However, cytotoxicity was not assessed in these experiments.  Because 
death of the cells would result in failure to convert PGF2α to PGFM, a possible 
explanation for the results may be overt cytotoxicity of PCB 153 on trophoblast cells. 
Because the isolation procedure for villous placental and chorion trophoblast cells 
was time-consuming, the yields were low and culture purity was unpredictable.  In 
subsequent experiments, intact gestational membrane Transwell cultures were used as the 
experimental model.  I hypothesized that PCB 153 would induce PGHS-2 and inhibit 
PGDH causing an overall increase of gestational membrane prostaglandin release.  
Because PGDH is primarily located in the chorion trophoblast cells, I expected that the 
increased prostaglandin release would be especially high on the choriodecidual side of 
the gestational membranes.  However, at PCB 153 concentrations up to 50 µM and 
exposures as long as 24 h, no effect was seen on prostaglandin release.  Preliminary 
immunohistochemical analysis of immunoreactive PGDH in post-exposure gestational 
membrane cryosections indicated that PGDH protein levels were drastically reduced in 
PCB 153-exposed membranes (data not shown).  However, these results were not 
reproducible.  It remains possible that the individual specimens were differentially 
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sensitized to PCB 153, but I am unable to determine the cause of the decrease in PGDH 
seen with that specimen.  
Limited data on cytokine release from gestational membranes exposed to 10 µM PCB 
153 for 1 or 4 h showed no increase in IL-6 secretion from amnion or choriodecidual 
sides of gestational membranes (data not shown).   
To determine whether PCB 153 caused sensitization of gestational membranes to 
LPS-induced inflammation, a co-exposure experiment was conducted on samples from 
one specimen.   However, no significant prostaglandin release was seen under these 
exposure conditions.  Because the experiment was only conducted on one specimen, it 
remains possible that this exposure scenario is still valid.  The particular specimen on that 
experimental day may have been a “non-responder” to LPS-induced inflammation.  In 
addition, LPS concentrations below a recognizable effect level were chosen, but 
experiments may need to be conducted with higher LPS concentrations to completely 
disprove the hypothesis.   
The absence of an effect on prostaglandin production by PCB 153 may be 
because of experimental conditions.  Choosing an appropriate concentration for 
polychlorinated biphenyl exposures is difficult.  Reports indicate that the intracellular or 
intratissue lipophilic toxicant concentrations vary from the medium concentration based 
on length of exposure, volume of medium and mass of the cells or tissue (Mundy, 
Freudenrich et al. 2004).  Based on the increased mass of the tissue relative to a 
corresponding cellular culture, similar medium concentrations between the two may 
result in quite disparate intracellular concentrations.  In addition, PCBs accumulate in 
biological material because of their lipophilic nature, and have half-lives measured on the 
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order of years.  Therefore, comparison of acute high concentrations in tissue culture to 










Figure 5.1.  Chemical structure of 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153).  The 
substitution of chlorine atoms in the 2 and 2' position prevents the two phenyl rings of 
PCB 153 from existing in a planar conformation. 
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Fig. 5.2.  15-hydroxy prostaglandin dehydrogenase activity is decreased in villous 
placental trophoblast cells treated with 50 µM PCB 153.  Isolated villous placental 
cells were not treated (NT, controls), or were treated with dimethyl sulfoxide (DMSO; 
solvent control), 50 µM PCB 153, or tumor necrosis factor-α (TNF-α; positive control) 
for 12 h.  Following treatment, cells were incubated with exogenous PGF2α (in the 
presence of indomethacin) for 2 h to measure conversion to the 13, 14-dihydro-15 keto 





Fig. 5.3.  PCB 153-dependent stimulation of PGE2 release from amnion or 
choriodecidual sides of intact human gestational membranes.   Prostaglandin E2 
(PGE2) was measured in medium from Transwell gestational membrane cultures 
following exposure to 50 µM PCB 153 compared to non-treated controls (NT), solvent 
controls exposed to dimethyl sulfoxide (DMSO), or positive controls exposed to LPS .   
(A) 1-hour exposure, (B) 4-hour exposure, (C) 8-hour exposure. Values are expressed as 
mean ± SEM (n= 4 specimens).  
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Fig. 5.4.  PCB 153-dependent stimulation of PGF2α release from amnion or 
choriodecidual side of intact human gestational membranes.   Prostaglandin F2α 
(PGF2α) was measured in medium from Transwell gestational membrane cultures 
following exposure to 50 µM PCB 153 compared to non-treated controls (NT), solvent 
controls exposed to dimethyl sulfoxide (DMSO), or positive controls exposed to LPS.  A) 
1-hour exposure (n = 2), B) 4-hour exposure (n = 4), C) 8-hour exposure (n = 3). Values 
































































































































































































Figure 5.5.  Gestational membrane PCB 153/LPS co-exposure experiment. A) 
Experimental design of PCB153/LPS co-exposure experiment.   Intact gestational 
membrane tissue was mounted on Transwell frames and allowed to equilibrate in tissue 
culture for 4 h.  Medium was removed and replaced with fresh medium containing PCB 
153 or dimethyl sulfoxide (DMSO; solvent control) for 18 h.  PCB 153 medium was 
removed and replaced with medium containing PCB 153 and LPS for 8 h.  B) PGE2 
concentrations in amnion or choriodecidual medium from intact gestational membranes 
treated with PCB 153 and DMSO.  A red x indicates PCB treatment or control (DMSO) 
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The extra-placental gestational membranes may be important for signaling the 
onset of preterm or term parturition. Secretion of inflammatory cytokines and 
prostaglandins from these tissues may directly or indirectly promote myometrial 
contractions, cervical effacement and dilation, or rupture of the membranes (Olson 2003).   
I optimized a novel system to culture intact gestational membranes from human 
pregnancies for the purpose of investigating side-specific prostaglandin and cytokine 
production caused by inflammatory stimuli (Chapter 2).  No animal model completely 
reflects the events preceding and during human parturition.  Furthermore, cell culture 
systems fail to incorporate important cell-to-cell and tissue-to-tissue signaling that is 
critical for understanding responses to inflammatory stimuli in this tissue.  As such, the 
human gestational membrane in vitro system described in this dissertation is a valuable 
investigative tool for research into mechanisms of parturition.   
One of the most difficult aspects of this system is the variability seen in response 
to experimental inflammatory stimulation.  Between-subject variability may be because 
of sample acquisition from subjects with diverse genetic backgrounds and environmental 
exposures, or differences in gestational age.  Within-subject variability may be related to 
sample location within the specimen.  Although both within- and between-subject 
variability may be valid reflections of physiological differences caused by the above-
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mentioned factors, it compromises the ability to detect differences related to experimental 
treatments.  Therefore, improvements in specimen collection, sampling, culture 
methodology and assay analysis were completed in hopes of reducing extraneous 
variability.  The objective was to be able to detect meaningful and statistically significant 
responses to experimental stimulus with a feasible number of gestational membrane 
specimens per experiment. 
Prostaglandins stimulate myometrial contraction, and it is likely that 
prostaglandins produced by the gestational membranes, especially those in the nearby 
choriodecidua, promote parturition (Olson 2003).  The dynamics of prostaglandin 
production and secretion from gestational membranes are important because preterm 
pathological activation of this pathway may cause preterm birth (Zakar and Hertelendy 
2001).  Differentiating the tissue and cellular sources of prostaglandins released in 
response to LPS stimulation in non-laboring gestational membranes may help clarify the 
role of prostaglandins in infection- and inflammation-associated preterm parturition.   
A limitation of the current system is that it uses only term gestational membranes.  
Because preterm responses to inflammatory stimuli may be different from term 
responses, extrapolation of the findings for preterm birth should be made with caution.  
For the purposes of optimizing the system and defining the overarching phenomena, term 
membranes sufficed.  However, it would be entirely possible and desirable for future 
research to include preterm membranes.  IRB procedures for such experiments would be 
more complex, requiring informed consent from the subjects and coordination with the 
Pathology Department.   
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Results from Chapter 3 show side-specific secretion of prostaglandin E2 (PGE2) 
and prostaglandin F2α (PGF2α), and indicate that amnion and choriodecidua respond 
independently to LPS.  Additionally, there is evidence for passage of the inflammatory 
signal across the membranes, because prostaglandin release was seen on the amnion side 
when only the choriodecidual side was stimulated.  Gestational membranes are many cell 
layers thick.  This anatomical structure of the membranes, combined with the inability of 
prostaglandins to diffuse passively across cellular membranes because of their anionic 
nature at physiologic pH, implies that a single prostaglandin molecule most likely can not 
traversing the entire gestational membrane.  We suggest, therefore, that transmittance of 
the inflammatory signal may be propagated across the tissues by a series of cytokine and 
prostaglandin “relays” whereby a signal is handed off from cell to cell. 
Although interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-8 (IL-8) and 
tumor necrosis factor-α (TNF-α) are all part of the acute inflammatory response, 
investigation of gestational membrane cytokine dynamics in Chapter 4 revealed 
distinctive cytokine secretion patterns in response to LPS stimulation.  The divergence of 
response patterns indicates that these cytokines each have unique regulatory mechanisms 
and specific functions within the gestational membrane tissue.  The subtle interplay 
among acute inflammatory cytokines is beginning to be revealed by this research. 
Cytokines are known modulators of prostaglandins (Bowen, Chamley et al. 2002), and 
knowledge of cytokine response to LPS stimulus may clarify mechanisms of increased 
prostaglandin secretion in exposed gestational membranes.  Further research exploring 
cytokine regulatory mechanisms and effector functions would illuminate the roles these 
proteins play in gestational membrane prostaglandin regulation.   
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Exposure of the amnion side of the gestational membranes to LPS caused 
significant levels of IL-6, TNF-α, PGE2 and PGF2α to be released by the amnion side of 
the membranes into the medium (data compiled from chapters 3 and 4 in Fig. 6.1).  
Lipopolysaccharide exposure of the amnion also caused IL-6, TNF-α and interleukin-10 
(IL-10) to be released by the choriodecidual side by an as-yet determined mechanism 
(thus, the wavy lines).  It is possible that IL-6 and TNF-α traverse the membranes to be 
secreted on the opposite side.  However, LPS treatment of the amnion side increased IL-
10 on the choriodecidual side but not the amnion side, indicating that the inflammatory 
signal propagates across the tissue.  This may occur by passage of a different cytokine 
such as TNF-α or IL-6 or by a theoretical “relay” type mechanism.  Potential future 
experiments could investigate the mechanisms of cytokine release from gestational 
membranes, including study of the passage of radiolabeled cytokines such as IL-6 or 
TNF-α across the membranes, analysis of cytokine mRNA or protein within the 
membranes, and inhibitor studies to detect critical components of the pathway that allow 
the signal to be initiated and propagated in the tissue.  Considering the complexity of the 
gestational membrane tissue and the relatively high number of cell membranes that a 
single molecule would have to cross to get from one side of the gestational membranes to 
the other, I suggest that a relay-type mechanism is most likely responsible for 
propagation of the inflammatory signal from one side of the gestational membranes to the 
other. 
Lipopolysaccharide treatment on the choriodecidual side caused a robust 
prostaglandin and cytokine response on the choriodecidual side, but only TNF-α, PGE2 
and PGF2α were released in significant amounts on the amnion side (data compiled from 
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Chapters 3 and 4 in Fig. 6.2).  The dampened response within the fetal compartment may 
be important for protecting the fetus from the inflammatory response.  Choriodecidual-
only LPS treatment simulates an ascending intrauterine infection from the vagina and 
may be the most clinically relevant model for considering gestational membrane 
prostaglandin and cytokine responses to LPS.  The alternate scenario whereby the 
infection originates in the intra-amniotic space is thought to be relatively rare (Romero, 
Espinoza et al. 2007).  
A comprehensive model to simulate ascending intrauterine infection was designed 
to incorporate prostaglandin and cytokine responses observed in medium from LPS-
treated gestational membranes in response to LPS exposure on the choriodecidual side of 
the membranes (Fig. 6.3).  I propose that PGHS-2 and TNF-α constitute the primary 
response to LPS and signal downstream events such as membrane rupture, cervical 
ripening and myometrial contractility via prostaglandin production and stimulation of 
additional cytokines. A by-product of the inflammatory response that spills over to the 
intramniotic space may be adverse fetal effects.  When the inflammatory response 
signaled by LPS is received by the choriodecidual cells, TNF-α may cause induction of 
PGHS-2, the inflammatory cytokines IL-6 and IL-8, and the collagen-degrading matrix 
metalloproteinases (MMPs). A secondary anti-inflammatory reaction facilitated by IL-10 
is proposed to down-regulate the response to control damage caused by inflammation. 
Tumor necrosis factor-α is a known inducer of prostaglandin endoperoxide H 
synthase-2 (PGHS-2; (Perkins and Kniss 1997) and may also limit catabolism of 
prostaglandins by inhibiting 15-hydroxy prostaglandin dehydrogenase (PGDH; (Mitchell, 
Goodwin et al. 2000).  Therefore, increases in TNF-α release may cause increases in 
 117
PGE2 and PGF2α  release by inducing enzymes of the prostaglandin metabolic pathway.  
Correlation of TNF-α release with prostaglandin release from one or both sides of the 
gestational membranes may shed light on regulation of prostaglandin synthesis on the 
opposite side of the membranes from LPS exposure.  Further research is needed to 
understand whether TNF-α itself or a signal for TNF-α release is transmitted  across the 
gestational membranes after exposure to an inflammatory stimulus such as LPS. .  
Previously, only cytokine passage across the placenta has been studied; no reports 
explicitly assessed cytokine passage across gestational membranes. 
The only anti-inflammatory cytokine measured in response to LPS stimulation 
was IL-10.  Previous research shows that IL-10 inhibits PGHS-2 in preterm placenta 
explant cultures (Hanna, Bonifacio et al. 2006).  Furthermore, IL-10 null mutant mice are 
more prone to preterm labor induced by LPS compared to wild-type mice (Robertson, 
Skinner et al. 2006). The latter reports suggest that down-regulation of PGHS-2 and 
subsequent decrease in prostaglandin output by IL-10 may be important for mitigating the 
inflammatory response and avoiding or lessening detrimental events leading preterm 
birth.  Potential roles for IL-10 in the inflammatory prostaglandin and cytokine response 
in gestational membranes warrant further investigation.   
Non-infectious sources of preterm inflammation leading to preterm labor are 
interesting to consider.  Inflammatory cytokines and prostaglandins are measured in 
gestational tissues from preterm births not associated with infection (Romero, Espinoza et 
al. 2007).  Potential modulators of inflammation are age of the mother and gestational 
age.  Exaggerated inflammatory responses can be seen in mice as they age  (Meador, 
Krzyszton et al. 2008).  Researchers hypothesize that dysfunction of the IL-10 anti-
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inflammatory response may explain why older mice have decreased ability to control 
inflammation (Meador, Krzyszton et al. 2008).  Based on this, it would be interesting to 
research whether human gestational membrane response to inflammatory stimuli is 
affected by age of the mother, and whether differences in IL-10 were associated with age.  
Preterm amnion cells respond more robustly to inflammatory stimuli compared to term 
amnion cells (Jung, Yoon et al. 2005).  Accounting for these non-infectious modulators 
of inflammation may shed light on variability of response seen from specimens collected 
from different women. 
Inflammatory toxicants might be an important source of non-infectious 
inflammation and yet another mechanism for maternal age to modulate the inflammatory 
response. Persistent organic toxicants bioaccumulate in organisms over time because of 
their long half-lives.  2,4,5,2’,4’,5-Hexachlorinated biphenyl (PCB 153) is one such 
persistent organic toxicant that is reported to have inflammatory effects.  Based on 
reports that PCB 153 caused induction of PGHS-2 and secretion of inflammatory 
cytokines in other cell types (Kwon, Lee et al. 2002) and that PCBs are associated with 
shortened gestational length in epidemiological studies (Taylor, Stelma et al. 1989), I 
hypothesized that PCB 153 would cause increased prostaglandin secretion by inducing 
PGHS-2  in gestational membranes.  However, results presented in Chapter 5 indicate no 
effect on prostaglandin production with PCB 153 treatment concentrations up to 50 µM 
and exposure times between 1 and 24 h.   
The absence of an effect on prostaglandin production by PCB 153 may be due to 
experimental conditions.  Choosing an appropriate concentration for polychlorinated 
biphenyl exposures is difficult.  Reports indicate that the intracellular or intratissue 
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lipophilic toxicant concentrations in experimental setups vary from the medium 
concentration based on length of exposure, volume of medium and mass of the cells or 
tissue (Mundy, Freudenrich et al. 2004; Barber, Walsh et al. 2006).  Based on the 
increased mass of the tissue relative to a corresponding cellular culture, similar medium 
concentrations between the two may result in quite disparate intracellular concentrations.  
In addition, PCBs accumulate in biological material because of their lipophilic nature, 
and PCB half-lives in humans are measured on the order of years (Jacobson, Fein et al. 
1984).  Therefore, comparison of acute high concentrations in tissue culture to chronic 
low concentrations seen in vivo may result in erroneous conclusions.   
Many other toxicants may cause inflammation in gestational tissues.  For 
instance, other PCB congeners may cause inflammation and play a role in prostaglandin 
release from gestational membranes.  Additional inflammatory toxicants to consider for 
research are lead (Jelliffe-Pawlowski, Miles et al. 2006), alcohol (Jaddoe, Bakker et al. 
2007), air pollutants (Leem, Kaplan et al. 2006) and phthalates (Latini, Massaro et al. 
2005).   
In addition to acting as inflammatory agents and directly causing preterm birth, 
anti-inflammatory toxicants might indirectly participate in events leading to preterm 
birth.  Toxicants that interfere with immune host defense could make it more difficult to 
fight off an infection.  For example, an individual with a certain toxicant exposure may 
be particularly susceptible to intrauterine invasion of normally commensal bacteria, such 
as occurs in bacterial vaginosis.  More work needs to be done to address the effects of 
immunosuppresive agents on pregnancy and parturition, including the potential for 
toxicants to decrease resistance to infection in gestational membranes. 
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Because of the increasing incidence of preterm birth and serious health 
consequences for mother and baby, it is important to develop research aimed at 
understanding pathways and signaling within gestational membranes.  My research 
indicates cytokine and prostaglandin signaling in gestational membranes that may 
provide the basis for further research into causes and results of intrauterine inflammation.  
The gestational membrane Transwell system provides an excellent model for furthering 
this goal.  Furthermore, the model system described herein is uniquely situated to be 
expanded for both epidemiologic as well as laboratory-based mechanistic research.  I 
envision experimental designs where large numbers of specimens are collected and data 
analysis incorporates multiple demographic variables, as well as mechanistic studies to 















Figure 6.1.  Prostaglandin and cytokine response to amnion-side lipopolysaccharide 
(LPS) stimulus.  LPS exposure to the amnion side of gestational membranes in 
Transwell culture stimulated prostaglandin and cytokine release into the amnion and 
choriodecidual medium.  Release of prostaglandins and cytokines on the amnion side 
may be due to direct effects in the amnion.  Release of cytokines on the choriodecidual 
side may be due to passage of amniotic cytokines across the membranes or the 


















Figure 6.2.  Prostaglandin and cytokine response to choriodecidual-side 
lipopolysaccharide (LPS) stimulus.  LPS exposure to the choriodecidual side of 
gestational membranes in Transwell culture stimulated prostaglandin and cytokine 
release into the amnion and choriodecidual medium.  Release of prostaglandins and 
cytokines on the choriodecidual side may be due to direct effects in the amnion.  Release 
of prostaglandin and cytokines on the amnion side may be due to passage of 
choriodecidual cytokines (TNF-α) across the membranes or the inflammatory signal may 
be propagated in another way. 
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Figure 6.3.  Theoretical model depicting lipopolysaccharide (LPS)-stimulated effects 
on cytokine and prostaglandin release in gestational membranes relating to 
downstream parturition-related events.  Because ascending microbial infection from 
the vagina may be the most clinically relevant route for intrauterine infection, the model 
shows LPS stimulation of the choriodecidual side.  In this model, the primary responses 
to LPS stimulation on the choriodecidual side of the gestational membranes are increases 
in tumor necrosis factor-α (TNF-α) and prostaglandin endoperoxide synthase-2 (PGHS-
2).  Induction of PGHS-2 leads to increased prostaglandin secretion (PGE2 and PGF2α) 
from the gestational membranes. PGF2α released from the choriodecidua causes 
myometrial contractions.  Induction of TNF-α increases matrix metalloproteinases 
(MMP) that result in membrane rupture and cervical ripening.  TNF-α also causes 
induction of other inflammatory cytokines such as interleukins-6 and 8 (IL-6 and IL-8, 
respectively).  Secondary induction of interleukin-10 (IL-10) down-regulates the 
inflammatory response.  Preterm delivery will depend on the ability of anti-inflammatory 
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